Neurotrophic dependency of sensory neurons in a co-culture model of porcine DRGs and human skin cells by Falkner, Susanne Martina
DIPLOMARBEIT
Titel der Diplomarbeit
Neurotrophic Dependency of Sensory Neurons in a Co-Culture Model of
Porcine DRGs and Human Skin Cells
angestrebter akademischer Grad
Magister/Magistra der Naturwissenschaften (Mag. rer.nat.)
Verfasserin: Susanne Martina Falkner
Matrikel-Nummer: 0304600
Studienrichtung (lt.
Studienblatt):
A490
Betreuer: Ao. Prof. Dr. Sigismund Huck
Wien, Juni 2009

The thesis was performed at
Beiersdorf AG, Hamburg
Skin Research Department
Group of Dr. Gitta Neufang
in cooperation with
The Faculty of Clinical Medicine, Mannheim
University Heidelberg
Group of Prof. Dr. Martin Schmelz

Acknowledgements
I am very grateful to Dr. Gitta Neufang, head of the group, Dr. Franz Stäb, head of the
skin research department and Dr. Horst Wenck, research director, for the opportunity
to perform this thesis at Beiersdorf AG, Hamburg. I encountered an ever inspiring and
supporting environment, excellent supervision by Dr._Neufang and continuous
encouragemnet to pursue new ideas.
Further I thank all colleagues at the skin research department for the pleasant
atmosphere and their assistance in all technical matters. Special thanks to Dr. Fatemeh
Navid, Dr. Nina Kurschat, Dr. Anil Jain and Tim Baumann for their valuable input,
hints, suggestions and inspiring discussions at all times.
I am very grateful to Prof. Dr. Martin Schmelz, Faculty of Clinical Medicine,
Mannheim, University of Heidelberg, for the opportunity to gain experience with
porcine DRG cultures within his group, as well as for his continued excellent
scientific assistance.
Special thanks to Elmar Forsch, who was most helpful with the excision of DRGs and
logistics.
I am also very grateful to Ao. Prof. Dr. Sigismund Huck for supervising the thesis and
offering continued valuable input and suggestions.
Finally, my gratitude belongs to my parents for their ever supportive, encouraging and
inspiring assistance that has always enabled me to accomplish and succeed in the
challenges ahead.
Special thanks also to Ara „silverback“ Hacobian for his scientific input, his constant
endeavor to train my interdisciplinary skills and for always having my back.

Page 7
Table of Content
Table of Content........................................................................................................ 7
1 Introduction ................................................................................................... 11
1.1 The cutaneous peripheral sensory nervous system .................................... 11
1.1.1 Anatomy of the cutaneous peripheral sensory nervous system .......... 11
1.1.2 Classification of sensory neurons...................................................... 13
1.1.3 Efferent functions of cutaneous sensory neurons............................... 16
1.2 Cutaneous neuropeptides.......................................................................... 18
1.2.1 Calcitonin gene related peptide, CGRP............................................. 18
1.3 Cutaneous neurotrophic factors ................................................................ 19
1.3.1 Nerve growth factor, NGF................................................................ 20
1.4 The role of peripheral sensory neurons in cutaneous disease..................... 21
1.5 Focus of the Diploma Thesis .................................................................... 21
2 Materials ........................................................................................................ 23
2.1 Antibodies................................................................................................ 23
2.2 Chemicals and Buffers ............................................................................. 23
2.3 Enzymes and Recombinant Proteins......................................................... 25
2.4 Assays and Kits........................................................................................ 26
2.5 Cell Culture Media and Supplements ....................................................... 26
2.6 Plastic ware and Consumables.................................................................. 28
2.7 Equipment and Instrumentation................................................................ 28
2.8 Cell Material ............................................................................................ 31
2.9 Software................................................................................................... 31
3 Methods .......................................................................................................... 33
3.1 Cell Biology............................................................................................. 33
3.1.1 Isolation and cultivation of human keratinocytes and fibroblasts....... 33
3.1.2 Cell counting of primary skin cells ................................................... 33
3.1.3 Cryopreservation of primary skin cells ............................................. 34
3.1.4 Isolation and cultivation of porcine dorsal root ganglion cells........... 34
3.1.5 Cell counting of DRGs via NucleoCounter ....................................... 35
3.1.6 Co-culture model of human skin cells and porcine DRGs ................. 36
3.2 Induction and manipulation of peripheral nerve fiber growth.................... 37
3.2.1 Effect of external human NGFβ on peripheral fiber growth .............. 38
Page 8
3.2.2 NGFβ sequestration via anti-NGFβ antibody.................................... 38
3.2.3 Effect of primary skin cells on peripheral fiber growth ..................... 38
3.2.4 Effect of NGFβ sequestration in supernatants of primary skin cells .. 39
3.2.5 Effect of conditioned media of primary skin cells on peripheral fiber
growth.............................................................................................. 39
3.2.6 Effect of NGFβ sequestration in conditioned media of primary skin
cells.................................................................................................. 39
3.3 Monitoring and analysis of peripheral fiber growth .................................. 40
3.3.1 Immunofluorescence (IF) staining of DRGs and primary skin cells in
co-culture ......................................................................................... 41
3.4 Characterization of nociceptive DRGs via IF staining .............................. 41
3.4.1 Immunofluorescence (IF) staining of DRGs ..................................... 42
3.5 Determination of the functionality of DRGs ............................................. 42
3.6 Immunohistochemistry............................................................................. 44
3.6.1 Cryosections human skin.................................................................. 44
3.6.2 Immunofluorescence (IF) staining of skin cryosections .................... 44
3.7 Protein Biochemistry................................................................................ 45
3.7.1 Quantitative analysis of CGRP ......................................................... 45
3.7.2 Quantitative analysis of NGFβ via Bio-Plex assay ............................ 45
3.7.3 Determination of total protein concentration..................................... 46
3.7.4 Expression and secretion of NGFβ in primary skin cells ................... 47
3.8 Molecular Biology ................................................................................... 47
3.8.1 RNA isolation of primary skin cells.................................................. 47
3.8.2 cDNA RT-PCR ................................................................................ 48
3.8.3 TaqMan® realtime PCR .................................................................... 48
3.9 Statistics................................................................................................... 49
4 Results ............................................................................................................ 51
4.1 Characterization of the co-culture system ................................................. 51
4.1.1 Effect of NGFβ on neuronal fiber growth ......................................... 52
4.1.2 Characterization of nociceptive DRGs and fibers via IF staining....... 57
4.1.3 Stimulation of DRGs and peripheral fibers ....................................... 59
4.2 NGF expression and secretion by human skin cells .................................. 64
4.2.1 Kinetics of NGFβ expression and secretion ...................................... 64
Page 9
4.2.2 NGFβ concentration of co-culture supernatants ................................ 66
4.3 Effect of primary skin cells on peripheral fiber growth ............................. 67
4.3.1 Peripheral fiber growth mediated by primary skin cells .................... 67
4.3.2 NGFβ independent fiber growth mediated by primary skin cells....... 70
4.3.3 Peripheral fiber growth mediated by conditioned media of primary skin
cells.................................................................................................. 71
4.4 Quantification of NGFβ independent neurite growth ................................ 72
4.5 Kinetics of NGFβ independent fiber growth............................................. 73
5 Discussion ....................................................................................................... 75
5.1 The co-culture system .............................................................................. 75
5.1.1 Effect of recombinant growth factors on sensory nerve growth......... 76
5.1.2 Quantitative analysis of nociceptive molecular markers in the
peripheral fibers ............................................................................... 76
5.1.3 Specific and unspecific stimulation of efferent functions of sensory
neurons............................................................................................. 77
5.2 Neurotrophic effects of human skin cells on sensory neurons ................... 80
5.2.1 Difference in morphology of peripheral fibers mediated by
keratinocytes and fibroblasts............................................................. 81
5.2.2 Kinetics of NGF independent growth mediated by keratinocytes ...... 81
5.3 Potential additional keratinocyte derived factors in sensory fiber outgrowth
– GDNF ................................................................................................... 82
6 Abstract .......................................................................................................... 83
7 Zusammenfassung ......................................................................................... 85
8 References ...................................................................................................... 87
9 Abbreviations ................................................................................................. 95
10    Index of Figures ............................................................................................. 97
11    Curriculum vitae............................................................................................ 99
Page 10
Introduction
Page 11
1 Introduction
1.1 The cutaneous peripheral sensory nervous system
Anatomically, the human nervous system is divided into the central nervous system,
CNS and the peripheral nervous system, PNS. While the CNS comprises the brain and
the spinal cord, the PNS consists of the efferent postganglionic and the sensory
afferent structures of the somatic and autonomic nervous system, including the twelve
cranial nerves.
In terms of physiological function, the nervous system is divided into the somatic
nervous system of conscious control and the autonomic nervous system, ANS of
involuntarily regulated, visceral functions. Both systems consist of afferent sensory
neurons and efferent motor neurons, as well as connecting interneurons. The sensory,
motor and interneurons of the autonomic nervous system in turn, are arranged in two
functional systems: The sympathetic and the parasympathetic autonomic nervous
system.
The peripheral sensory nervous system therefore includes: The sensory afferents of
the somatic nervous system and the sensory sympathetic and parasympathetic
afferents of the autonomic nervous system, also called visceral sensory neurons. All
of them innervate to varying extent the human skin [1] [2].
1.1.1 Anatomy of the cutaneous peripheral sensory nervous system
The cell bodies of somatic and visceral afferent sensory neurons are located in the
dorsal root ganglia, DRG and in the ganglia of the cranial nerves. All sensory neurons
are considered pseudounipolar, with the exception of several cranial nerves which
contain bipolar neurons [3]. Pseudounipolar neurons possess one bifurcated axon, the
long distal process innervating the peripheral target tissue and the short proximal
process projecting to the spinal cord. The sensory roots leaving the ganglia converge
with the motor roots originating in the brain stem and the spinal cord and form mixed
cranial nerves and the 31 pairs of spinal nerves. They branch and proceed in mixed
bundles to their peripheral target tissues.
Cutaneous nerves enter the skin via the subcutis which is mainly built of connective
and adipose tissue. Nerve bundles proceed to the subsequent dermis, which primarily
consists of fibroblasts that secrete the main components of the extracellular matrix, in
particular the glycoproteins elastin, fibronectin and collagen [4]. The dermis further
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contains microvascular blood and lymphatic vessels, as well as the skin appendages
and immune cells [5] [6]. In the dermis nerve bundles loosen and axonal fibers branch
to build the dermal nerve plexi. Autonomic motor and sensory fibers, mainly of the
sympathetic and to minor extent of the parasympathetic system, innervate the
arteriovenous anastomoses, the microvascular blood and lymphatic vessels, the
sebaceous and sweat glands and the hair follicles with the erector pili muscles [7].
However, autonomic fibers do not enter the superficial epidermal layer of the skin. In
contrast, the somatic sensory neurons either terminate in the dermis or in the
epidermis. In the dermis somatic sensory neurons end as encapsulated
mechanoreceptors (Pacinian, Meissner and Ruffini corpuscles), innervate the hair
follicles or form free sensory nerve endings [8]. In the epidermis the somatic sensory
neurons generally terminate as free nerve endings or in complex with Merkel cells
located in the epidermal basal layer [9]. The predominant cell type of the epidermis
constitute keratinocytes with up to 85 to 95 percent, followed by melanocytes,
Langerhans cells and Merkel cells. Keratinocytes undergo terminal differentiation, a
mechanism of controlled cell death that results in denucleated, cornified cells of the
horny layer [10] [11]. Keratinocytes of different stages of differentiation form the
characteristic squamous stratified epithel which is subclassified into the 5 epidermal
layers: stratum basale , stratum spinosum, stratum granulosum, stratum lucidum and
stratum corneum (Figure 1).
Unmyelinated somatic sensory fibers branch extensively at the dermal-epidermal
borders and create a three dimensional network of sensory fibers throughout the
epidermis [12] [13].  The most superficial fibers reach into the stratum granulosum.
Different sensory fiber types terminate in distinct keratinocyte layers and may serve
different functional purpose, as indicated by Zylka MJ. in 2005 [14].
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1.1.2 Classification of sensory neurons
Sensory neurons can be classified into four subgroups according to their extent of
myelination and conduction velocity: Aα, Aβ, Aδ and C fibers [15]. In short, Aα
fibers possess the largest diameters of 12 – 20 µm at a maximum conduction velocity
of 120 m/s, followed by Aβ fibers  (6 – 12 µm; max. 70 m/s), Aδ (1 – 5 µm;
Figure 1: Topography of nerve fibers in the skin
A) Human dermal nerve plexus and B) neuronal fibers entering the epidermis (arrows);
Cryosections of human punch biopsies, neurites labeled with mouse monoclonal anti-
SMI312 and goat anti-mouse Alexa 594, keratinocytes labeled with rabbit polyclonal
anti-cytokeratin 1/10 and goat anti-rabbit Alexa 488, nuclei labeled with DAPI (Zeiss
Axiovert S100; 100x magnification)
C )  In-vitro co-culture of sensory neurites and primary human keratinocytes;
Keratinocytes labeled with rabbit polyclonal anti-wide spectrum cytokeratin and goat
anti-rabbit Alexa 488, neurites labeled with mouse monoclonal anti-SMI312 and goat
anti-mouse Alexa 594 (Zeiss Axiovert S100; 200x magnification)
D)  Sketch of the squamous morphology of the human epidermis (modified from
Eucerin®)
Stratum corneum
Stratum lucidum
Stratum granulosum
Stratum spinosum
Stratum basale
Basal membrane
Free nerve endings
A B
C D
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max._30_m/s) and C fibers (0,2 – 1,5 µm; max. 2 m/s). Sensory Aα nerve fibers
innervate the proprioceptive organs of muscles, the golgi tendon organ and the muscle
spindle [16]. Sensory Aβ fibers form the secondary afferent endings in the muscle
spindle and innervate all mechanorecpetive structures in the dermis (1.1.1). Sensory
Aδ and C fibers, terminate as free nerve endings in the skin, whereas only C fibers
proceed into the epidermal layer (Figure 2). Subtypes of both fiber types respond to
temperature and osmotic changes, as well as mechanical, chemical and noxious
stimuli [17].
Transient receptor potential channel subfamilies have been implicated as molecular
sensors involved in a variety of the above indicated sensations [18]. Warming and
cooling sensation is transmitted via TRPV1 – 4 and TRPA1 and M8, respectively.
TRPC5 has been implicated in osmosensing [19] and the TRPN and P subfamilies
have been related to mechanosensing. In addition, TRPV, TRPA and M subtypes have
been detected on nociceptive fibers [20] [21] and several exogenous and endogenous
ligands to TRP channels have been identified [22] [23].
Stratum corneum
Stratum granulosum
Stratum spinosum
Stratum basale
Epidermis
Aδ (lightly myelinated)
Peptidergic C-fiber
(unmyleinated)
Non-peptidergic C-fiber
Aβ (thickly myelinated)
Figure 2: Different classes of somatic sensory fibers innervate the human skin
Somatic sensory fibers derived from DRGs innervate different layers and structures of
the skin. Aβ fibers innervate mechanoreceptive skin appendages, Aδ fibers terminate
as free nerve endings in the dermis, while unmyelinated C fibers terminate in complex
with Merkel cells or as free nerve endings in the epidermis. (modified from
Lumpkin&Caterina 2007)
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Aδ and C nerve fibers that signal pain in response to noxious stimuli are generally
termed nociceptors. Different nociceptor subtypes are defined based on the fiber type
and conduction velocity, the soma size, the modalities of stimulation and the
characteristics of pain sensation transmitted, for instance sharp, pungent or burning
[24].
In addition, different types of nociceptive sensory neurons can be subdivided
according to their expression of specific molecular markers, including neurofilaments,
neuropeptides, enzymes, receptors, as well as their neurotrophic dependency [24]. In
rat, approximately 40 % of DRGs stain for NF200, heavy neurofilament 200_kDa, a
marker for myelinated neurons. Only 10_% of NF200+ neurons are nociceptive, the
nociceptive Aδ fibers. NF200+ Aδ  and NF200- fibers are subclassified into
peptidergic and non-peptidergic nociceptors. Peptidergic neurons contain
neuropeptides as substance P (SP) or calcitonin gene related peptide (CGRP). They
depend on nerve growth factor (NGF) for survival and sustainment of their receptive
properties [25]. Accordingly, peptidergic neurons express the NGF high affinity
receptor TrkA. Non-peptidergic neurons express the specific surface proteoglycan
versican that binds the plant lectin isolectin B4 (IB4) [26] [27]. They are dependent on
glial cell-line derived neurotrophic factor (GDNF) and express its receptor tyrosine
kinase Ret and the co-receptors GFRα (1-4). TRPV1 is expressed in subpopulations
of both, peptidergic and non-peptidergic neurons (Figure 3).
Notably, molecular markers show no specificity for target tissues, considerable
overlap exists [28] and marker expression varies substantially between species [29]
[28] and developmental stages [30] [31]. Despite these limitations, above indicated
markers remain valuable for the general classification of sensory neurons and are
combined and extended with different functional properties [32].
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1.1.3 Efferent functions of cutaneous sensory neurons
The classical view of sensory nerves in the skin assigns afferent sensory transmission
and efferent release of neurotransmitters, neuropeptides and neurohormones to
separate anatomical entities. However, present knowledge strongly indicates that
sensory reception and efferent release of neuromediators occur at the very same
sensory afferent ending. A more and more complex auto and para-neuroendocrine
system between nerve fibers, cutaneous cells, immune cells and the microvascular
system in the skin becomes apparent  (Figure 4) [24] [33] [34].
Sensory C and Aδ fibers have been shown to produce and release neuropeptides, as
substance P (SP) or calcitonin gene related peptide (CGRP), neurotransmitters as
acetylcholine (ACh) and catecholamines (norepinephrine, NE; dopamine) and
neurotrophins as NGF. Respective cognate receptors are expressed on numerous cell
types in the skin including keratinocytes, fibroblasts, endothelial cells, smooth muscle
cells, Merkel cells, mast cells and leukocytes. Further, indicated cell types have been
reported to produce and secrete various neuromodulatory factors themselves [35].
Sensory afferents release neuropeptides in response to a wide range of external and
internal stimuli, including extreme temperature, low pH, nitric oxide, UV radiation,
ATP or other factors released during tissue injury. Neuropeptides bind and act on
adjacent cutaneous cells, which in turn secrete more neuropeptides and
Peptiderg
40%
Non-
Peptiderg
60%
20% of Adelta
NF200+
50% of C-fibers
CGRP+
SP+
TrkA+
NGF dep.
IB4+
Ret
GFRa1-4
GDNF dep.
50% of C
fibers
Figure 3: Molecular markers of
nociceptive neurons
Nociceptive neurons are divided into
peptidergic and non-peptidergic
neurons by the expression of
molecular markers. Peptidergic: SP+,
CGRP+, TrkA+ and dependent on
NGF; Non-peptidergic: IB4+, Ret+,
GFRα+ and dependent on GDNF.
Note that 20 % of NF200+ Aδ fibers
and 50 % of C fibers are peptidergic;
Values given for immunofluorescent
studies in rats  (based on McMahon
2005, Priestly_2002).
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neuromodulatory factors. The so created autonomic feedback loops play an important
role in skin homeostasis, but also in neurogenic inflammation, pain or pruritus and is
misregulated in a number of cutaneous diseases [36] [37] [38].
Figure 4: Efferent functions of sensory neurons
Auto and para-neuroendocrine interaction of sensory afferents, skin cells, immune
cells and the microvascular system using the example of the neuropeptides SP and
CGRP: Acitvated sensory afferents release neuropeptides that activate mast cells and
vascular endothelial cells, resulting in the release of cytokines, neurotrophic factors
and neuropeptides. (Julius & Basbaum 2001)
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1.2 Cutaneous neuropeptides
Neuropeptides are small peptides built of 4 to approximately 40 amino acid residues.
Members of the same neuropeptide family are usually transcribed in one large
precursor molecule, named pre-pro-neuropeptide. Proteolytic cleavage and
posttranslational modifications are required to finally genereate the active
neuropeptide. In general, neuropeptides are ligands of G protein coupled receptors
(GPCR), thus modulating the excitability of the target cells. Besides the strong
expression of neuropeptides and their receptors in the CNS and in the peripheral
terminals, they are expressed in nearly all non-neuronal tissues. This allows an
extensive crosstalk of neuronal and non-neuronal cells and the integration of different
body functions and systems [39].
In the skin, Aδ and C fibers and various cutaneous cell types (1.1.3) have been shown
to produce and release neuropeptides including tachykinins (SP, neurokinins NK)
[40], VIP/secretin peptides (VIP, PACAP) [41], CGRP peptides [42], opioids and
POMC derived peptides [43] [44], as well as endocannabinoids [45]. In summary,
they regulate functions in the skin as vasoconstriction and -dilatation and sweat
production and -secretion, thus maintaining the skin’s temperature and water balance.
Neuropeptides possess extensive immune modulatory capabilities. They stimulate the
release of pro and anti-inflammatory cytokines, induce the expression of vascular
adhesion molecules and exert trophic effects on immune cells, fibroblasts and
endothelial cells. Both, cytokines and neuropeptides in turn influence the excitability
of sensory afferent nerve endings in the skin [38]. Thus, neuropeptides do not only
promote inflammation and wound healing, but play a major role in neuropathic pain
and pruritus.
1.2.1 Calcitonin gene related peptide, CGRP
The superfamily of calcitonin gene-related peptides includes CGRP, calcitonin (CT),
amylin and adrenomedullin. CGRP1 and CT are encoded in the human CALC I gene,
whereas CGRP2 is derived form the CALC II gene. CGRP1 and CGRP2 are built of
37 amino acids and differ in 3 residues. The two subtypes of CGRP1, CGRP1α and
CGRP1β, are genereated by alternativ splicing and differ in 1 residue [42] [46].
CGRP1α is the predominant subtype present in sensory neurons, while CGRP1β is
found in enteric neurons [47].
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Based on affinity and pharmacological studies, two types of receptors have been
proposed, CGRP-R1 and CGRP-R2. CGRP-R1 has been identified as a heterodimer
of a 7 transmembrane calcitonin-receptor-like receptor (CRLR) and one of three
single transmembrane receptor-activity-modifying-proteins, RAMP1. RAMP1
transports CRLR to the plasma membrane. The existence of the CGRP-R2 receptor
has recently been questioned as its molecular components remain elusive [48].
In rat skin CGRP is expressed in approximately 51 % of sensory neurons [49] and is
found in colocalization with either SP or somatostatin (SST) [50]. CGRP positive
fibers are associated with the dermal microvascular system [51]. CGRP was shown to
exert potent effects as vasodilator [52] and directly stimulates endothelial cell
proliferation, indicating a possible role in angiogenesis and wound healing [53].
CGRP positive fibers are also found closely associated with keratinocytes,
melanocytes [54], Merkel cells, Langerhans cells [55] and mast cells [56], which are
involved in inflammatory processes. However, some controversy regarding the role of
CGRP during inflammation exists. It was shown that CGRP in general exerts an anti-
inflammatory effect [57]. On the other hand, it also stimulates neutrophil and
monocyte adhesion to microvascular endothelial cells (HDMECs) [58] and the release
of pro-inflammatory cytokines, as TNFα, from mast cells [59] [60].
1.3 Cutaneous neurotrophic factors
Per definition, a neurotophic factor exerts trophic, survival and growth effects on
neurons. Neurotrophic factors are expressed in the CNS and the peripheral target
tissues. They promote and guide innervation during development and ensure the
maintainance of neuronal subtypes in the adult organism. The concept of neurotrophic
factors was first described by Rita Levi-Montalcini and Stanley Cohen with the
discovery of NGF [61].
Subtypes of cutaneous nerve fibers show selective dependency on different
neurotrophic factors. They express specific tyrosine kinase receptors that are
internalized together with the bound ligand and retrogradely transported to the cell
somata, thereby ensuring the survival of the respective neuron [62] [63]. In the skin,
neurotrophic factors of the neurotrophin and TGFβ superfamilies are expressed by
various cell types including keratinocytes [64] [65], fibroblasts [66], endothelial cells
[67] [68] and Merkel cells [69]. Dysregulation of cutaneous neurotrophin levels has
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been implicated in several cutaneous diseases, causing pain, hypersensitivity and
neuropathic conditions [24] [70].
1.3.1 Nerve growth factor, NGF
Nerve growth factor (NGF) is the most prominent member of the superfamily of
neurotrophins that also includes brain derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4). Mature NGF exists in two forms, a
high molecular weight hexameric complex built of 2α : 2β : 2γ subunits named 7S
NGF and the βNGF homodimer. 7S NGF is expressed at high levels in murine
submaxillary glands, but is absent in most other murine tissue or other species [71].
Accordingly, it was shown that the biological functions of NGF are mediated via its β
homodimer [72] [73]. The NGFβ subunit is synthesized as 40 kDa glycosylated
proNGF precursor molecule [74]. Pro NGF is released upon neuronal activity and
processed to mature NGF of 13 kDa in a plasminogen/ tissue plasminogen activator
(tPA) dependent manner in the extracellular space [75].
The NGFβ homodimer binds two classes of receptors, the high affinity receptor TrkA
and the low affinity receptor p75. Besides NGF, p75 is bound by all members of the
neurotrophin family, as well as the precursor proNGF. While the activation of p75 has
been implicated in apoptosis [76], TrkA activation induces signaling to promote the
survival and maintenance of the target cell. The phosphorylated receptor-ligand
complex is internalized in signaling endosomes that are transported retrograd to the
cell somata [77]. Simultaneously, TrkA activates downstream signaling via MAP
kinase pathways [78], thereby inducing posttranslational and transcriptional
modifications of several ion channels [79].
NGF is essential for the maintenance of the nociceptive phenotype of peptidergic C
and Aδ fibers and is a key regulator of nociception in the periphery. It directly
influences the sensitivity of nociceptive afferents via sensitization of receptors as
TRPV1 [80] or bradykinin receptors [81] and stimulation of TRPV1 expression [82].
Furthermore, the production of neuropeptides such as SP and CGRP is regulated by
NGF [83]. Neuropeptides in turn play a key role in inflammation and sensitization of
nociceptive afferents (1.2) and mediate the release of pro and anti-inflammatory
cytokines (TNFα, IL1α/β, IL6, IL8 and IL10), as well as NGF from skin and immune
cells [38] [60] [84].
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1.4 The role of peripheral sensory neurons in cutaneous
disease
A crucial role for cutaneous sensory neuronal afferents has become apparent in
several cutaneous diseases, especially in Atopic Dermatitis (AD) and Psoriasis. Both
are chronic inflammatory skin diseases with marked dysregulation in keratinocyte
proliferation and differentiation, resulting in skin barrier dysfunction. Plaques of
inflamed skin exhibit massive infiltration of immune cells and extensive accumulation
of allergen specific IgE [85] [86]. Though, the type of T-cell infiltration presents the
main difference between psoriatic and atopic inflamed plaques [87].
Psoriatic and AD skin exhibit increased neuronal fiber density and a marked increase
in SP and CGRP positive fibers [88] [89]. As indicated in 1.2 and 1.3 SP and CGRP
stimulate the release of cytokines and neurotrophins from cutaneous cell types and
immune cells. Accordingly, increased levels of NGF in psoriatic and AD skin have
been detected [90]. Cytokines, neuropeptides and NGF in turn cause sensitization of
nociceptive afferents and the stimulation of already infiltrated immune cells.
In summary, sensory afferent neurons are not only considerably affected in cutaneous
diseases, but account for the sustained and persistent inflammation, pain and pruritus,
collectively referred to as neurogenic inflammation.
1.5 Focus of the Diploma Thesis
In this work, the local influence of dermal and epidermal skin cells on sensory
afferent nerve growth is investigated using a novel in-vitro co-culture system of
porcine DRGs and human primary skin cells.
In a first attempt, the co-culture system is established and characterized. The
sensitivity of the system in repsonse to the neurotrophic factor human NGFβ is
examined. Induced peripheral fibers are classified using common nociceptive markers
(1.1.2) and the functionality of cultured neurons is analyzed by stimulating the
efferent function of sensory neurons (1.1.3).
Secondly, the effects of primary human keratinocytes and fibroblasts on peripheral
sensory fiber growth and morphology is examined. Are skin cells sufficient to induce
fiber outgrowth in the co-culture system? Do keratinocytes and fibroblasts exert
different effects? Does endogenously produced NGF play a role in skin cell mediated
effects and are any other factors beside NGF involved?
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2 Materials
2.1 Antibodies
Primary Antibodies
Rabbit polyclonal anti-TrkA Abcam, Cambridge UK
Rabbit polyclonal anti-TRPV1 Abcam, Cambridge UK
Rabbit polyclonal anti-PGP9.5 Abcam, Cambridge UK
Mouse monoclonal anti-CGRP Abcam, Cambridge UK
Mouse monoclonal anti-Fibroblast Surface Protein Abcam, Cambridge UK
Rabbit polyclonal anti-wide spectrum Cytokeratin Abcam, Cambridge UK
Rabbit polyclonal anti-Cytokeratin 1/10 Covance, Emeryville USA
Mouse monoclonal anti-Pan-Axonal Neurofilament Covance, Emeryville USA
Mouse monoclonal anti-Myelin CNPase Covance, Emeryville USA
Goat polyclonal anti-NGFβ, affinity purified R&D, MN USA
Isolectin GS-IB4, Alexa Fluor 488 conjugate Molecular Probes, OR USA
Secondary Antibodies
Alexa Fluor 488, Goat anti-mouse IgG (H+L) Molecular Probes, OR USA
Alexa Fluor 488, Donkey anti-goat IgG (H+L) Molecular Probes, OR USA
Alexa Fluor 488, Goat anti-rabbit IgG (H+L) Molecular Probes, OR USA
Alexa Fluor 594, Goat anti-mouse IgG (H+L) Molecular Probes, OR USA
Alexa Fluor 594, Goat anti-rabbit IgG (H+L) Molecular Probes, OR USA
2.2 Chemicals and Buffers
All solutions were prepared with ultra pure water (ddH2O) using a Milli-Q academic
water purification system.
Aceton Merck, Darmstadt GER
Albumin, Bovine (cohnVfraction >96%) Sigma-Aldrich, Munich GER
Bayer Baysilone, highly viscous VWR, Darmstadt GER
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Calciumchloride Merck, Darmstadt GER
Capsaicin Sigma-Aldrich, Steinheim GER
Capsazepin A.G.Scientific, San Diego USA
DAPI, dilactate Sigma-Aldrich, Munich GER
D-Glucose Merck, Darmstadt GER
Dimethyl sulfoxid (DMSO) Sigma-Aldrich, Munich GER
Donkey Serum Sigma-Aldrich, Munich GER
Dulbecco’s PBS (1x w/o Ca2+, Mg2+) Invitrogen, Karlsruhe GER
Dulbecco’s PBS (10x w/o Ca2+, Mg2+) Invitrogen, Karlsruhe GER
Essential Aminoacids (50x) Invitrogen, Karlsruhe GER
Ethanol, abs. Merck, Darmstadt GER
Fetal bovine serum PAA, Linz Austria
Fluka H2O, RNase/DNase free Sigma-Aldrich, Steinheim GER
Fluorescence Mounting Media Dako, Glostrup Denmark
Gentamycin (10mg/mL) Invitrogen, Karlsruhe GER
Goat Serum Sigma-Aldrich, Munich GER
HEPES 1M Invitrogen, Karlsruhe GER
Horse Serum, heat inactivated Invitrogen, Karlsruhe GER
Isopropanol Merck, Darmstadt GER
L-Glutamin (200mM) Invitrogen, Karlsruhe GER
Magnesiumchloride Sigma-Aldrich, Steinheim GER
Methanol Merck, Darmstadt GER
Methyl-Cellulose Sigma-Aldrich, Munich GER
OCT-Media Tissue-Tec® Leica Microsystems, Wetzlar GER
Paraformaldehyde Sigma-Aldrich, Steinheim GER
PBS (1x w/o Ca2+, Mg2+) PAA, Linz, Austria
Penicillin-Streptomycin (10.000 U/mL each) Invitrogen, Karlsruhe GER
Penicillin-Streptomycin
(5000 U/mL, 5000µg/mL) Invitrogen, Karlsruhe GER
Percoll GE Healthcare, Uppsala Sweden
Poly-L-Lysine (0,1%) Sigma-Aldrich, Munich GER
Potassiumchloride Merck, Darmstadt GER
Sigmacote SL-2 Sigma-Aldrich, Munich GER
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Sodiumchloride Merck, Darmstadt GER
Triton X-100 Sigma-Aldrich, Steinheim GER
Tween Cayman, Michigan USA
Trypan blue (0,4%) Sigma-Aldrich, Munich GER
Ultrasonol 7, neutral Roth, Karlsruhe GER
HEPES basal buffer for DRG stimulation (Ref.)
HEPES 25 mM
Supplements:
Invitrogen, Karlsruhe GER
135 mM
3,5 mM
2,5 mM
1,0 mM
3,3 mM
0,1 %
-
NaCl
KCl
CaCl2
MgCl2
Glucose
BSA
PH 7,4
HEPES high potassium for DRG stimulation
HEPES basal
Supplements:
50 mM KCl
HEPES Capsaicin for DRG stimulation
HEPES basal
Supplements:
50nM Capsaicin
2.3 Enzymes and Recombinant Proteins
Trypsin EDTA PAA, Linz Austria
Collagenase Invitrogen, Karlsruhe GER
Dispase II (2,4U/mL) Roche, Penzberg GER
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Human NGFβ Sigma-Aldrich, Munich GER
Mouse NGF 7S Merck, Darmstadt GER
2.4 Assays and Kits
BCA-Assay Uptima Interchim, Montlucon France
Bioplex Cell Lysis Kit Bio-Rad, Munich GER
NGFβ Single Plex Kit Bio-Rad, Munich GER
Human CGRP EIA Kit Cayman, Michigan USA
TaqMan 18s Gene Expression Assay Applied Biosystems, Foster City USA
TaqMan high capacity cDNA RT Kit Applied Biosystems, Foster City USA
TaqMan human NGFβ Gene Expression Assay Applied Biosystems, Foster City USA
TaqMan universal PCR MasterMix Applied Biosystems, Foster City USA
RNase free DNase Set Qiagen, Hilden GER
RNeasy Mini Kit Qiagen, Hilden GER
2.5 Cell Culture Media and Supplements
DMEM culture medium for primary fibroblasts (Gibco)
DMEM high glucose (4,5g/L) with phenolred
Supplements:
Invitrogen, Karlsruhe GER
10% v/v
10 µl/mL
50 U/mL
50 µg/mL
Fetal bovine serum
Glutamax
Penicillin
Streptomycinsulfate
DMEM cryomedium for primary fibroblasts (Gibco)
DMEM cryomedium with DMSO Invitrogen, Karlsruhe GER
7,5 % v/v DMSO
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DMEM medium for dorsal root ganglion cell isolation (Sigma)
DMEM high glucose with Gentamycin
Supplements:
Sigma-Aldrich, Munich GER
5 µg/mL Gentamycin (10mg/mL)
KGM-2 culture medium for primary keratinocytes (Lonza)
KBM-2 w/o Ca2+
Supplements:
Lonza, Walkersville MD USA
Bovine pituitary extract (BPE)
Epinephrine
Gentamycin, Amphotericin-B
Human epidermal growth factor (hEGF)
Hydrocortisone
Insulin
Transferrin
Ca2+ 0,1 mM
KGM-2 cryomedium for primary keratinocytes (Lonza)
KGM cryomedium with DMSO and fetal bovine serum Lonza, Walkersville MD USA
20% v/v
7,5% v/v
Fetal bovine serum
DMSO
F12 culture media for primary dorsal root ganglion cells (Sigma)
F12 basal medium 500 mL
Supplements:
Sigma-Aldrich, Munich GER
10% v/v
10 ng/mL
1,5 mL
2,5 mL
5 mL
Horse serum
Human NGFβ
Essential aminoacids (50x)
L-Glutamin (200 mM)
Penicillin-Streptomycin (10.000 U/mL)
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2.6 Plastic ware and Consumables
6 well plates Greiner, Nürtingen GER
96 well plates Greiner, Nürtingen GER
96 well optical reaction plate, MicroAmp Applied Biosystems, Darmstadt
Adhesion films, MicroAmp Applied Biosystems, Darmstadt
Bottle top filters (150mL, 250mL) Nalgene, Lawrence KS USA
Cell culture dishes, 35mm x 10mm Becton Dickinson (BD), USA
Cell culture flasks (25, 75, 185, 500 cm2) Greiner, Nürtingen GER
Cell strainer Nylon 70 µm Becton Dickinson (BD), USA
Cover glass, 12 mm, 25 mm diameter VWR, Darmstadt GER
Cover glass, rectangular Menzel-Glass, Braunschweig GER
Cryotubes, 1,5 mL Nunc, Wiesbaden GER
Dumont Nr.5 forceps Reiss, Mainz GER
Eppendorf tubes (0,5, 1, 1,5 mL) Eppendorf, Hamburg GER
Falcon tubes (15 mL, 50 mL) Greiner, Nürtingen GER
Glass syringe, Luer lock 2 mL Fortuna Optima, Wertheim GER
Latex gloves powder free Kimberly-Clark, Mainz GER
Needles, 21 gauge Unimed, Lausanne CH
Neubauer chamber and cover glass Brand, Wertheim GER
Pasteur pipettes, plugged and non-plugged VWR, Darmstadt GER
Sterile biopsy instruments (scissors, forceps) Aesculap, Hammacher GER
Superfrost microscope slides Menzel-Glass, Braunschweig GER
Super PAP pen, large EMS, Munich GER
2.7 Equipment and Instrumentation
Analytical balances
BP211D precision balance Sartorius, Göttingen GER
Autoclaves
Varioklav 135S H+P, Oberschleißheim GER
Technoklav IBS integra biosciences, Chur CH
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Bioplex System
Bioplex 2200 System Bio-Rad, Munich GER
Cell Couting devices
Neubauer hemocytometer Schreck, Hofheim GER
Nucleo Counter Chemometec, Gydevang Denmark
Centrifuges
Centrifuge 5415 R Eppendorf, Hamburg GER
Heraeus Megafuge 1.0R ThermoScientific, Schwerte GER
Heraeus Multifuge3 S-R ThermoScientific, Schwerte GER
Cooling units
-196°C Cryostorage System K10 Taylor-Wharton Theodore, AL USA
-80°C ultra low temperature freezer Liebherr, Ochsenhausen GER
-20°C freezer Liebherr, Ochsenhausen GER
+4°C refrigerator Bosch, Munich GER
Cryotom
Leica CM3050S Leica Microsystems, Wetzlar GER
Ice machine
ZBE 30-10 Ziegra-Ice machines, Isernhagen GER
Incubators
HERAcell 150 Heraeus, Hanau GER
HERAcell 240 Heraeus, Hanau GER
Lamina Flow Workbenches
HERAsafe KS 12 Kendro, Hanau GER
HERAsafe Kendro, Hanau GER
Magnetic stirrers and heating plates
Big Squid IKA-Works, Staufen GER
VMS C4 VWR, Darmstadt GER
Microscopes
Axiovert S100 Zeiss, Göttingen GER
Confocal Laser Scanning Microscope Olympus, Hamburg GER
Leica MZ6 Leica Microsystems, Wetzlar GER
MCX 1600 Micros, Vienna Austria
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Orbital shaker
Thermo mixer comfort, plate shaker Eppendorf, Hamburg GER
MS 1 Minishaker IKA, NC USA
PCR machines
DNA Engine Biozym, Oldendorf GER
7900 HT Fast Real-Time PCR System Applied Biosystems, Foster USA
pH-Meter
763 Multi-Calimatic Knick, Berlin
Photometer
Spectra Max 250 Molecular Devices, Sunnyvale USA
Nanodrop ND-1000 Peqlab, Wilmington USA
Pipettes
Micropipettes
Reference 0,5-10 µL
Reference 0,5-20 µL
Reference 10-100 µL
Reference 100-1000 µL
Reference 500-2500 µL
Eppendorf, Hamburg
Eppendorf, Hamburg
Eppendorf, Hamburg
Eppendorf, Hamburg
Eppendorf, Hamburg
Multichannel pipettes manual
Finpipette manual (12-channel) 50-300
Finpipette manual (8-channel) 50-300
Finpipette manual (8-channel) 5-50
Labsystems, Helsinki Finland
Labsystems, Helsinki Finland
Labsystems, Helsinki Finland
Pipetboy acu IBS Integra Biosciences, Chur CH
Vacuum System and Suction devices
Vacusafe comfort IBS Integra Biosciences, Zurich CH
Miniport Hassheider, Köln GER
Water purification system
Milli-Q academic Millipore, Eschborn GER
Water baths
GFL 1002 GFL, Burgwedel GER
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2.8 Cell Material
Human cell material was derived from skin biopsies supplied by clinical cooperation
partners. The average age of donors was 56,6 years, ranging from 34 to 74 years.
Upon removal, skin biopsies were immediately cooled (4°C), placed on DMEM
soaked membranes and subjected to the isolation of dermal fibroblasts and epidermal
keratinocytes the same day.
Dorsal root ganglion cells were isolated from porcine spines (sus scrofa domestica)
kindly provided by the lab of Prof. Dr. Martin Schmelz, University of Heidelberg. The
spine of piglets was removed between postnatal day 2 and 5, cleaned with ice cold
PBS, cut in half and stored in pre-cooled (4°C) DMEM. The samples were kept on ice
during transportation and the subsequent isolation of dorsal root ganglia.
2.9 Software
AnalySIS® Version 3.2 Soft Imaging System, Münster GER
AxioVision Version 4.7 Zeiss, Göttingen GER
Bioplex Manager Bio-Rad, Hercules USA
Graphpad Prism 4 Graphpad Software, San Diego USA
ImageJ http://rsbweb.nih.gov/ij/
Leica for CLSM Olympus, Hamburg GER
ND-1000 V3.3.0 Peqlab, Wilmington USA
RQ Manager 1.2 Applied Biosystems, Foster USA
SDS 2.3 analysis software Applied Biosystems, Foster USA
SoftMax Pro Version 2.0.1 Molecular Devices, Suuyvale USA
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3 Methods
3.1 Cell Biology
All Cell Biology techniques were performed under sterile conditions. Cell material
employed for in-vitro and co-culture experiments comprised of keratinocytes
≤_passage 3 and fibroblasts ≤ passage 4 isolated from human skin biopsies, as well as
dorsal root ganglion cells (DRGs) derived from porcine spines (sus scrofa domestica).
3.1.1 Isolation and cultivation of human keratinocytes and
fibroblasts
Until the isolation of keratinocytes and fibroblasts human skin biopsies were cooled
(4 °C) and nurtured by a DMEM soaked membrane. First, subcutaneous and adipose
tissue were removed and the biopsies were cut into small pieces of 3 mm edge length.
Following a short disinfection in 70 % ethanol and PBS with penicillin and
streptomycin (50 U/mL, 50 µg/mL), the biopsy pieces were subjected to 2 hours of
enzymatic digest in dispase-II (2 U/mL) at 37 °C. The epidermis was subsequently
stripped off the dermis, incubated additional 10 min in 1x Trypsin (PAA) at 37 °C and
then pressed through a 70 µm cell strainer. Dissociated keratinocytes were collected,
resuspended in KGM-2 (Lonza) and seeded into 75 cm2 cell culture flasks.  Medium
was changed every second day and cells were transferred into the next bigger cell
culture flask after reaching 80 % confluence.
The dermis was placed into the cavities of a 6-well plate. After becoming adherent,
the pieces were covered with DMEM (Gibco) and cultivated at 37 °C in 5 % CO2.
Until the outgrowth of fibroblasts, medium was changed every 4-5 days, later every 2-
3 days. After reaching confluence, the dermis pieces were removed and the fibroblasts
were seeded into cell culture flasks.
3.1.2 Cell counting of primary skin cells
The cell count of primary keratinocytes and fibroblasts was determined previously to
cryopreservation and seeding into co-culture chambers or 6-well plates. Skin cells
were trypsinized and resuspended in KGM-2 (Lonza) or DMEM (Gibco),
respectively. The cell count was determined using a Neubauer chamber. To exclude
dead cells from count, Trypan blue was added in a 1:1 ratio. The missing integrity of
dead cell membranes allows the diffusion of the dye into the cytoplasm, thus the
discrimination between viable and dead cells.
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3.1.3 Cryopreservation of primary skin cells
1x10^6 cells were resuspended in 1 mL of keratinocyte or fibroblast cryomedium.
Cells were gradually frozen in isopropanol chambers at –80 °C and stored at –196_°C
in a cryostorage system.
For resuspension cell vials were quickly thawed at 37° C and immediately seeded into
75 cm2 cell culture flasks at a density of approximately 1x10^4 cells per cm2. To limit
the effect of cryomedium supplements as DMSO, medium was changed the following
day.
3.1.4 Isolation and cultivation of porcine dorsal root ganglion cells
(DRGs)
The spine of piglets was removed, cleaned with ice cold PBS, cut in half and stored in
pre-cooled (4 °C) DMEM. The samples were kept on ice during excision and
subsequent cleaning of dorsal root ganglia. D-PBS without Ca2+ Mg2+ was used for all
washing steps.
Each piece of spine was cut in half along the medial axis and the dorsal root ganglia
were excised from both sides of the vertebral canal. A binocular microscope was used
to remove the ventral and dorsal axonal radices, as well as the dura mater. Cleaned
DRGs were transferred to collagenase (740 U/mL in DMEM with Gentamycin) and
incubated 3x 45 min at 37°C. Every 45 min half of the collagenase solution was
replaced. Following two washing steps the DRGs were subjected to an additional
10_min of digest in 1x Trypsin (PAA) at 37 °C. DRGs were subsequently dissociated
using a coated, fire polished Pasteur pipette. The cells were separated from fiber
material of the extracellular matrix by Percoll density gradient centrifugation (20 %
Percoll) and resuspended in F12 with 10 ng/mL human NGFβ (huNGFβ).
The cell count was determined using a NucleoCounter. 16x10^4 dorsal root ganglion
cells were seeded into the middle compartment of a co-culture chamber and cultivated
at 37 °C in 5 % CO2. Medium was changed every second day.
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Figure 5: Excision of the DRGs of a porcine spine
A) – C) The spine is cut in half along the medial axis. D) DRGs are excised from the
vertebral canal.
3.1.5 Cell counting of DRGs via NucleoCounter
DRGs compose of a heterogeneous mixture of sensory neuron cell bodies of different
size associated with small glial cells, often referred to as satellite cells. To obtain an
exact, reliable and reproducible cell count for dissociated dorsal root ganglion cells
ChemoMetec’s NucleoCounter was used.
The NucleoCounter is basically a fluorescence microscope with an integrated optical
imaging and analysis system. It accounts for different cell size, cell viability and
errors due to the aggregation of cells, by cell lysis and by counting the fluorescent
labeled nuclei.
A small sample volume of 50 µL is subjected to lysis by low pH (solution A),
followed by a stabilizing solution B. The mixture is sucked into the NucleoCasette, a
small device combining flow channels with immobilized propidium iodide and a
measurement chamber of defined volume. Propidium iodide intercalates between the
base pairs, is excited by green light of 535 nm and emits red light of 617 nm. The
NucleoCounter determines the total amount of fluorescent nuclei in the measurement
A B
C D
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chamber. Correction for cell viability is achieved by measuring the amount of nuclei
and therefore dead cells, labelled in non-lysed cell suspension.
Equal volume of dissociated DRG cell suspension, solution A and solution B were
mixed and subsequently sucked into the NucleoCasette. The number of viable cells
was obtained from measuring the untreated DRG cell suspension, and subsequent
subtraction from the total DRG cell count.
3.1.6 Co-culture model of human skin cells and porcine DRGs
In-vivo the peripheral terminals of sensory neurons in the skin are clearly separated
from their cell bodies in the dorsal root ganglia and thus located in a completely
different microenvironment. This particular anatomical and physiological feature
constitutes a major drawback in the development of accurate in-vitro models of the
peripheral sensory network of the skin.
Two major problems are to be solved: First, the peripheral axonal fibers and their cell
bodies have to be spatially separated. Second, non-neuronal cells in the periphery e.g.
skin cells require cultivation media different from medium optimized for dorsal root
ganglion cells.
In cooperation with the lab of Prof. Dr. Martin Schmelz, Ruprecht-Karls University of
Heidelberg, a culture chamber was developed that allows the cultivation of neuronal
somata and their axonal processes in separate compartments. Due to a silicon seal that
is largely impermeable to liquids between these compartments, the co-cultivation of
skin cells within the axonal “peripheral” compartment was possible.
Cultivation-chambers were prepared 2-3 days before the isolation of the DRGs and
stored at 4 °C until testing the leak tightness of the seal. 6-well plates were coated
with poly-L-lysine (0,1 %) over night, washed with sterile PBS and dried at RT.
Using a metal ridge, parallel grid lines spaced 300µm apart were scratched into the
coated surface of each 6-well cavity. Two parallel lines of a sugar polymer were
subsequently applied rectangular to the scratched grid lines. Sterile silicone was
applied on the edges of co-culture chambers using a glass syringe with a 21-gauge
needle. The chambers were subsequently placed into the cavities of the 6-well plate,
on top of the sugar polymer.
A sterile weight of approximately 300 g was placed on top of the chambers for several
seconds to generate a tight seal between the chamber compartments. Following 1 h of
sterilization under UV-light at RT, the middle compartment was filled with F12
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medium (Sigma) and placed at 37 °C over night. Thus, leaky chambers excluded from
subsequent experiments.
16x10^4 dissociated dorsal root ganglion cells were seeded into the middle
compartment and cultivated in F12 (Sigma) with 10 ng/mL huNGFβ. Following over
night incubation and adherence of DRGs, chambers were again checked for
impermeable seals. Subsequently, the “peripheral” side chambers were loaded with
the respective potential axonal growth cues, NGFβ or skin cells. Loading of the side
chambers stated time point d = 0 of the cultivation period. Co-culture chambers were
cultivated for 10 days at 37 °C in 5 % CO2. The medium of each compartment was
changed every second day.
3.2 Induction and manipulation of peripheral nerve fiber
growth
The principle of the co-culture chamber is based on eliciting peripheral axonal fiber
growth in the side compartments, whereas the dorsal root cell bodies are cultivated in
the middle chamber. Notably, cultivation conditions in the middle chamber were
optimized for DRGs, whereas side chambers were loaded with potential growth cues.
Fiber outgrowth induced by huNGFβ, skin cells and conditioned media was
investigated. Respective cultivation media only (KGM-2, DMEM, F12) served as
negative controls and experiments were run in duplicates. Co-culture chambers were
cultivated for 10 days at 37 °C in 5 % CO2. The medium of each compartment was
changed every second day.
PM NS
Figure 6: Sketch of the co-culture chamber
DRGs are seeded into the middle compartment (M), axonal processes extend into the
peripheral side compartments (P) guided by grid lines (light blue). Growth cues:
neurotrophic factor NGFβ (N), skin cells (S)
(S) skin cells, (M) middle chamber, (P) peripheral chamber, (N) neurotrophic factors
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Peripheral fiber growth was observed using an optical microscope on day 4 or 5,
day_6 and day 10. Pictures of each neurite in the side chamber were taken and
subjected to analysis (see 3.3).
3.2.1 Effect of external human NGFβ on peripheral fiber growth
Due to its well-characterized neurotrophic effect on peripheral sensory neurons,
huNGFβ  was used to set up and evaluate the co-culture system. Increasing
concentrations of NGFβ, 0,04 ng/mL, 0,2 ng/mL, 1 ng/mL, 5 ng/mL and 10 ng/mL in
F12 (Sigma), were loaded into the side compartments of co-culture chambers.
3.2.2 NGFβ sequestration via anti-NGFβ antibody
To selectively block the growth of neurites mediated by huNGFβ, an affinity purified
anti-NGFβ antibody (R&D) was applied. This antibody was developed to block the
biological activity of NGFβ, as previously shown in an 3H-thymidine incorporation
assay with TF-1 cells [91].
To investigate the inhibition of the biological activity of NGFβ, both NGFβ and anti-
NGFβ  antibody were mixed in the side compartments. 2µg/mL antibody and
10_ng/mL huNGFβ in F12 (Sigma) were incubated for 10 min at RT prior to loading.
Growth of peripheral fibers was monitored and analyzed as described in 3.3.
Additionally, a complexation assay was conducted, to detect free, non-sequestered
NGFβ in solution using the Bioplex assay (3.7.2). 10 ng/mL huNGFβ in F12 (Sigma)
were mixed with increasing concentrations of anti-NGFβ antibody: 0,01 µg/mL,
0,05_µg/mL, 0,1 µg/mL, 1 µg/mL and 2 µg/mL. Following 15 min incubation at RT
the remaining amount of NGFβ in solution was quantified with a Bioplex assay.
3.2.3 Effect of primary skin cells on peripheral fiber growth
To investigate the ability of primary skin cells to induce peripheral fiber growth,
keratinocytes and fibroblasts were seeded into the side compartment of the co-culture
chambers.
Skin cells were trypsinized and resuspended in KGM-2 (Lonza) or DMEM (Gibco),
respectively. The cell count was determined using a Neubauer hemocytometer.
1x10^4 cells were seeded close to the border of the side compartment using a sterile
insert. In parallel, supernatants of the side compartments were subjected to NGFβ
Bioplex assays to determine the amount of secreted NGFβ. Every second day
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previously to the change of the media, supernatants were collected and stored at
–80_°C until NGFβ quantification.
3.2.4 Effect of NGFβ sequestration in supernatants of primary skin
cells
To selectively neutralize the effect of NGFβ secreted by primary skin cells, an affinity
purified anti-NGFβ antibody (R&D) was applied, as described in 3.2.2.
Using the NGFβ concentration measured in the supernatants of keratinocytes and
fibroblasts as a guide value, 0,1 µg/mL antibody were applied to equal an
approximately 1000-fold excess of antibody to its epitope. The successful
complexation of free NGFβ by the antibody was controlled using a Bioplex assay.
Every second day previously to the change of the media, supernatants were collected
and stored at –80 °C until NGFβ quantification.
3.2.5 Effect of conditioned media of primary skin cells on
peripheral fiber growth
It was investigated, whether conditioned media of keratinocytes and fibroblasts are
able to mimic the effect of primary skin cells seeded into the side compartments.
Medium of skin cells cultured for two days in 185 cm2 culture flasks exhibiting
>_80% confluence was collected and stored at –80 °C. Conditioned media were
subjected to 5 min centrifugation at 10.000 rpm directly before being loaded into the
side compartments.
3.2.6 Effect of NGFβ  sequestration in conditioned media of
primary skin cells
To selectively inhibit the effect of secreted NGFβ in conditioned media, an affinity
purified anti-NGFβ antibody (R&D) was applied, as described in 3.2.2.
The NGFβ concentration measured in conditioned media of keratinocytes and
fibroblasts served as guide values to determine the antibody concentration that equals
an approximately 1000-fold excess of antibody to its epitope. The successful
complexation of free NGFβ was controlled using a Bioplex assay.
Conditioned medium and 0,1 µg/mL antibody were incubated for 15 min at RT
previously to loading of the side compartments and determination of the free NGFβ
content.
Methods
Page 40
3.3 Monitoring and analysis of peripheral fiber growth
Peripheral fiber growth was observed on day 4 or 5, day 6 and day 10 with an optical
microscope. Pictures of each process or several mosaic pictures of adjacent areas of
the side comparment were taken using AxioVision 4.7 software. Thus, double counts
of processes were avoided.
Subsequent analyses of fiber length were conducted with ImageJ and AnalySIS®
Version 3.2. Total peripheral fiber growth of a given side compartment was
determined as the sum of the length of each individual grown fiber in µm, termed
cumulative peripheral neurite length (CPNL). Occasional reanalysis of random chosen
data sets were conducted and revealed similar results.
Figure 7: Analysis of total
growth of peripheral fibers.
100µm were used as reference
scale to determine the pixel / µm
ratio.
1
2
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5
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3.3.1 Immunofluorescence (IF) staining of DRGs and primary skin
cells in co-culture
Peripheral fibers in co-culture with skin cells were subjected to immunofluorescence
(IF) staining for histological identification on day 10. Keratinocytes were stained with
anti-wide-spectrum cytokeratin antibody (Abcam) [92], fibroblasts with anti-
fibroblast surface protein antibody (Abcam) [93] and axonal processes were stained
using the pan_axonal neurofilament marker SMI312 (Covance) [94]. IF staining was
conducted as described in 3.4.1.
List of Antibodies Dilution Source
Rabbit polyclonal anti-wide spectrum Cytokeratin 1:1000 Abcam
Mouse monoclonal anti-Fibroblast Surface Protein 1:200 Abcam
Mouse monoclonal anti-Pan-Axonal Neurofilament 1:2000 Covance
Alexa Fluor 488, Goat anti-rabbit IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 488, Goat anti-mouse IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 594, Goat anti-mouse IgG (H+L) 1:1000 Mol.Probes
3.4 Characterization of nociceptive DRGs via IF staining
The nociceptive phenotype of dorsal root ganglion cells and their peripheral fibers
was displayed using the nociceptive, peptidergic markers calcitonin-gene-related-
peptide (CGRP) and the receptor tyrosine kinase TrkA, the non-peptidergic marker
Isolectin B4 (IB4) and the ambiguously expressed vanilloid receptor TRPV1. IF
staining of DRG somata in the middle compartment, as well as their peripheral fibers
in the side compartment was conducted.
Monitoring and analysis of peripheral fibers and their respective marker expression
was performed as described in 3.3. The fraction of peripheral fiber length expressing
each marker compared to total fiber growth was investigated. Individual fractions of
marker expression were stated as percentage of cumulative peripheral neurite length
(CPNL).
List of Antibodies Dilution Source Ref.
Mouse monoclonal anti-Pan-Axonal Neurofilament 1:2000 Covance [94]
Rabbit polyclonal anti-PGP9.5 1:1000 Abcam [95]
Mouse monoclonal anti-CGRP 1:500 Abcam [96]
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List of Antibodies Dilution Source Ref.
Rabbit polyclonal anti-TrkA 1:200 Abcam [97]
Rabbit polyclonal anti-TRPV1 1:200 Abcam n.d.
Isolectin GS-IB4, Alexa Fluor 488 conjugate 1:200 Mol.Probes [98]
Alexa Fluor 594, Goat anti-mouse IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 594, Goat anti-rabbit IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 488, Goat anti-mouse IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 488, Goat anti-rabbit IgG (H+L) 1:1000 Mol.Probes
3.4.1 Immunofluorescence (IF) staining of DRGs
Primary and secondary antibodies were diluted in PBS with 1 % goat serum and all
steps were carried out at RT, if not stated otherwise.
Co-culture chambers were carefully washed with PBS and the cells were fixed in 4 %
Paraformaldehyde (PFA) for 15 min. Following two washing steps, cells were
permeabilized in 0,1 % Triton in PBS (PBS-T) for 10 min. After two additional
washing steps, 1 hour of incubation with blocking solution (1 % BSA) took place.
Primary antibodies were diluted directly before use and over night incubation was
carried out at 4 °C in humid chambers.
Subsequently, chambers were washed with 1 % goat serum in PBS and subjected to 3
hours of secondary antibody incubation at RT in the dark. Following two washing
steps with 1 % goat serum in 0,1 % PBS-T and a third with PBS only, DAPI solution
was applied for 15 min. Chambers were washed with PBS and subjected to increasing
concentrations of ethanol (50 %, 70 %,  96 %). The co-culture chambers were
carefully removed using surgical blades. Fluorescence Mounting Media (Dako) and
coverslips of 25 mm diameter were used for mounting. 6-well plates were allowed to
dry over night at 4 °C before examination under the microscope.
3.5 Determination of the functionality of DRGs
To determine whether cultured DRGs and their peripheral fibers are functional and
therefore can be stimulated to release neurotransmitter, a modified version of the
stimulation assay employed by Hingtgen in 2006 was conducted [99]. In rats, CGRP
is expressed in over 40 % of peptidergic DRGs and therefore comprises the most
abundant neuropeptide. Hence, CGRP release upon stimulation was chosen as readout
parameter.
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To examine, whether stimulation of DRG somata in the middle compartment is
transmitted to the side compartment, stimuli application was restricted to the middle
chamber. Neuropeptide secretion was detected in the middle and side compartment,
respectively.
Co-culture chambers cultivated in the presence of 10 ng/mL huNGF were subjected to
stimulation at day 10. Two subsequent stimulation cycles were conducted to examine
repetitive stimulation. The incubation period was set to 10 min at 37 °C in 5 % CO2.
After every period supernatants were collected and stored at –20 °C until detection of
CGRP concentrations (3.7.1).
At the start of each cylce, chambers were carefully washed with HEPES buffer. To
determine basal CGRP release, the cultures were initially incubated with HEPES.
Subsequently, stimuli were applied to the middle compartments, whereas HEPES is
loaded into the side compartments. Following careful washing steps, a second
stimulation cycle was performed.
Figure 8: Scheme of the stimulation assay
Respective stimuli (high potassium, 50 mM; TRPV1 agonist capsaicin, 50 nM) and the specific
TRPV1 antagonist capsazepine (500 nM) are applied to the middle compartment alone and in
various combinations; Secreted CGRP is detected in the supernatants of the side and middle
compartment by EIA. 1 cycle of stimulation comprises 10 min incubation with HEPES,
followed by 10 min stimulation.
DRGs NeuritesNeurites
K+ 50 mMCapsaicin 50 nM
HEPES HEPESStimulation K+/ CPS Stimulation K+/ CPS
CGRP / supernatant
Capsazepine 500 nM
10min 10min 10min 10min
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First, stimulation with 50 mM potassium was used to unspecifically cause
depolarization and neurotransmitter release of the DRGs. Second, a specific, ligand-
receptor mediated stimulation was performed using the TRPV1 agonist capsaicin
(CPS). TRPV1 is expressed in a subpopulation of DRGs in-vivo, as well as in culture
(examined in 3.4). 50 nM capsaicin in HEPES basal were applied.
To assess the potential of the system to specifically block the ligand-receptor
mediated stimulation, the synthetic TRPV1 antagonist capsazepine (CPZ) was co-
applied with CPS and high potassium, respectively. Capsazepine was employed in a
10-fold excess over capsaicin at a concentration of 500nM and was co-applied with 50
mM potassium.
3.6 Immunohistochemistry
Punch biopsy material of normal and atopic human skin was derived from clinical
cooperation partners. Following excision biospies were rinsed with PBS, mounted in
Tissue-Tec® and subjected to cryopreservation in liquid nitrogen. Biopsy material
was stored at –80 °C until preparation of cryosections.
3.6.1 Cryosections human skin
Vertical sections of 5 µm and 50 µm were genereated using a Leica CM3050S
cryotom. 4 to 5 sections were transferred to one microscope slide. The sections were
dried for 1 hour at RT and subsequently fixed with icecold aceton. Sections were
stored at –20 °C until immunofluorescence staining.
3.6.2 Immunofluorescence (IF) staining of skin cryosections
Anti-pan-axonal neurofilament antibody SMI312 (Covance) was used to monitor
peripheral neuronal structures in normal and atopic skin. Epidermal structures were
stained with anti-cytokeratin 1/10 antibody (Covance). All antibodies were diluted in
1 % BSA.
Aceton fixed cryosections were washed with PBS and blocked with 3 % BSA for
1_hour at RT. Primary antibody incubation was performed over night at 4 °C using a
humid chamber. The next day sections were washed with 0,1 % Triton in PBS (PBS-
T), followed by PBS only. Subsequent secondary antibody incubation took place for
2_hours at RT in the dark. After another washing step with PBS sections were
subjected to DAPI staining for 15 min at RT, followed by dehydration using
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increasing concentrations of ethanol (50 %, 70 %, 96 %). Sections were mounted with
fluorescent mounting media (Dako) and dried over night at 4 °C.
List of Antibodies Dilution Source Ref.
Mouse monoclonal anti-Pan-Axonal Neurofilament 1:2000 Covance [94]
Rabbit polyclonal anti-Cytokeratin 1/10 1:1000 Covance n.d
Alexa Fluor 594, Goat anti-mouse IgG (H+L) 1:1000 Mol.Probes
Alexa Fluor 488, Goat anti-rabbit IgG (H+L) 1:1000 Mol.Probes
3.7 Protein Biochemistry
3.7.1 Quantitative analysis of CGRP
To detect the concentration of CGRP released by DRG stimulation, a human CGRP
Enzyme Immunoassay Kit (Cayman) was used. This EIA is based on a sandwich-
enzyme-immunoassay. The 96-well plate is precoated with mouse monoclonal anti-
CGRP antibody that captures free CGRP protein. The acetylcholinesterase (AChE)
conjugated tracer (Fab’) binds specfically to a different epitope of CGRP. The
enzymatic activity of AChE hydrolyzes an ester bond of the added Ellman’s reagent,
forming a yellow compound. The intensity of the color is proportional to the amount
of CGRP. The absorbance is measured at 405 nm, unspecific absorption was detected
at 650 nm. The limit of detection is stated with 2 –5 pg/mL.
Precoated plates were washed 5 times with washing buffer. 100 µL of Ellman’s
reagent, medium (for non-specfic binding), standards (1000 pg/mL – 7,81 pg/mL) and
samples were employed. 100 µL of anti-CGRP AChE tracer were added except for
cavities with blank. Following 20 hours of incubation at 4 °C and several washing
steps, 200 µL of Ellman’s reagent was added. Absorbance is measured after 60 min of
incubation at RT.
3.7.2 Quantitative analysis of NGFβ via Bio-Plex assay
To detect the concentration of NGFβ in supernatants of co-culture chambers, in
conditioned media and in the supernatants of primary skin cells, a Bio-Plex Cytokine
Assay was used. In general it is possible to quantitatively detect 27 different cytokines
and growth factors in parallel in one sample.
Methods
Page 46
This assay is based on the simultaneous detection of the identity and the quantity of a
protein of interest. Notably, an optimized flow cytometer with two lasers and a high-
speed signal processor is necessary. The solid phase of an ordinary EIA is replaced by
fluorescence color coded microbeads that are covalently bound to the capture
antibodies. The color code of the microbead is clearly identified by the laser system of
the flow cytometer and designates the protein type.
A secondary biotinylated antibody recognizes a different epitope of the protein of
interest. Streptavidin-Phycoerythrin is added and binds the biotinylated detection
antibody. The intensity of the fluorescent signal after excitation at 532 nm, compared
to a standard curve determines the quantity of the protein.
The 96-well microplate was pre-wet with assay buffer. After each step, the liquid was
removed by using vacuum filtration. The multiplex bead solution was added to each
well, followed by washing steps. 50 µL of standard and samples were added and
incubated for 30 min at RT. Following washing steps the detection antibody was
added to each well and incubated for 30 min at RT. After an additional washing step,
streptavidin-PE was applied to each well, followed by another 10 min of incubation.
Finally, beads were resuspended in assay buffer and immediately subjected to
detection.
3.7.3 Determination of total protein concentration
The concentration of NGFβ detected in the supernatants of primary skin cells
(see_3.7.4.) was normalized to total protein concentrations.
The cells were lysed with cell lysis buffer (Biorad) with protease inhibitors and
subjected to the BCA Protein Quantification Kit (Uptima). This colorimetric assay is
based on an improved Biuret reaction. Cu2+ are reduced to Cu+ by oxidation of
peptide bonds. Cu+ ions are subsequently bound by the specific chelator
Bicinchoninic acid and form a water soluble purple complex. Absorbance at 562 nm
is proportional to the protein concentration, which is determined using a standard
curve.
Standards and samples are measured in triplicates. 5 µL of blank (lysis buffer),
standards (2 mg/mL – 0,062 mg/mL) and samples were mixed with 200 µL of BCA
reagent and incubated for 30 min at 37 °C. Absorption was measured at 562 nm using
the Spectra Max 250 (Molecular Devices).
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3.7.4 Expression and secretion of NGFβ in primary skin cells
To investigate the expression and secretion of NGFβ by keratinocytes and fibroblasts,
the following assays were conducted.
3x10^4 primary skin cells were seeded into 6-well chambers and cultivated for 10
days at 37 °C in 5 % CO2. Supernatants were collected at day 2, 4, 6 and 10. Samples
were stored at –80 °C until the detection of NGFβ with the Bioplex Assay, as
described in 3.7.2. In parallel skin cells were lysed using cell lysis buffer (Biorad)
with protease inhibitors and total protein concentrations were detected using the BCA
assay (3.7.3). The NGFβ concentration of the supernatants was normalized to the total
protein concentration.
In a second setup skin cells were lysed using a guanidine-thiocyanate containing
buffer (Qiagen) and subjected to mRNA isolation at day 2, 4, 6 and 10. Total mRNA
was isolated with Qiagen spin columns (3.8.1) and subjected to reverse transcription
using the TaqMan high capacity cDNA RT Kit (3.8.2). Expression levels of NGFβ
were detected with real time PCR using the TaqMan human NGFβ Gene Expression
Assay (3.8.3).
3.8 Molecular Biology
3.8.1 RNA isolation of primary skin cells
Skin cell lysates collected as described in 3.7.4 were subjected to mRNA isolation
using the Qiagen RNeasy-Kit. This kit selectively excludes RNAs smaller than 200
nucleotides. Lysates were mixed with 70 % ethanol and transferred to RNeasy spin
columns. RNA efficiently binds the silica-based membrane of the columns. The
supernatant was removed by short centrifugation. Co-isolated DNA was degraded
with DNase, followed by washing steps. mRNA was eluted in 50 µL of RNase free
water and subjected to quantification and quality testing using a nanodrop ND1000
photometer (Peqlab). At neutral pH an absorbance of 1 at 260 nm correlates with 44
µg of RNA per mL. A ratio of 260 nm to 280 nm between 1.9 and 2.1 refers to
comparatively pure RNA. The mRNA samples were stored at –80 °C until reverse
transcription.
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3.8.2 cDNA RT-PCR
1 µg of mRNA is conducted to reverse transcription in a total volume of 100 µL using
the TaqMan high capacity cDNA RT Kit (Applied Biosystems). Per reaction 10 µL
RT buffer, 4 µL dNTPs, 10 µL primer and 5 µL of reverse transcriptase were
employed.
PCR Program for RT-PCR
25 °C 10 min
37 °C 120 min
4 °C ∝
3.8.3 TaqMan® realtime PCR
Expression levels of NGFβ mRNA were detected by real time PCR using the TaqMan
human NGFβ Gene Expression Assay (Applied Biosystems). In parallel, expression
of the endogenous control 18S rRNA was determined. Expression levels of NGFβ
mRNA were normalized using the respective levels of 18S rRNA. Experiments were
run in duplicates.
Assay Catalog Number
NGFβ Hs00171458_m1
18S Hs99999901_s1
The TaqMan® system is based on a DNA probe with the fluorsecent reporter FAM™
bound to the 5 prime end and the quencher NFQ™ bound to the 3 prime end. The
probe binds its complementary sequence within the amplified region between the
primer pairs. During amplification the Taq polymerase degrades the probe. Both
fluorscent reporter and quencher are released. Due to the lack of proximity of the
quencher to the reporter, a fluorescent signal can be detected. Excitation of the
fluorescent signal is achieved at 488 nm and emission takes place at 518 nm.
Therefore, fluorescence intensity correlates with copy numbers of the amplified
sequence.
3,5 µL of each primer pair were mixed with 33,5 µL Universal PCR Mastermix
(Applied Biosystems). 3 µL of cDNA and 30,5 µL RNsae-free water were added and
mixed. 25 µL total reaction volume was employed. 30 cycles of amplification were
run and PCR protocol is indicated below.
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PCR Program for TaqMan® PCR
50 °C 2 min
95 °C 10 min
95 °C 15 sec
60 °C 60 sec
4 °C ∝ sec
30x
Relative quantification is achieved by calculating ΔCT and RQ (2-ΔΔct) from measured
CT values according to the following scheme:
Value Calculation
CT Cycle threshold
ΔCT CTNGFβ - CT18S
ΔΔCT CTNGFβ - CT18S - ΔCTKo
RQ 2-ΔΔct
3.9 Statistics
Statistical analysis was conducted using Graphpad Prism 4. Data were analysed
assuming sampling from Gaussian distribution. Statistical tests included matched one
and two-tailed t-tests, repeated measures one-way ANOVA for comparison of three or
more matched groups, as well as two-way ANOVA for comparison of three or more
groups analyzed for two or more conditions. Appropriate post tests included
Dunnett’s test to compare several groups to control, a test for linear trend and the
Bonferroni test for selected pairs of groups. All values are stated as arithmetic mean ±
standard deviation (SD). Significances are reported according to the following
definition:
P value In words Symbol
≤ 0,001 Extremely significant ***
0,001 – 0,01 Highly significant **
0,01 – 0,05 Significant *
> 0,05 Not significant ns
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4 Results
4.1 Characterization of the co-culture system
In-vitro models of the peripheral sensory network face two major problems to
accurately mimic the in-vivo situation: First, the peripheral terminals of the sensory
neurons have to be spatially separated from their cell bodies in the dorsal root ganglia.
Second, non-neuronal cells in the periphery require completely different
microenvironments and thus, different cultivation conditions. To address questions
about the growth dependency of the peripheral axonal fibers in the skin, current mixed
culture models of DRGs and skin cells [94] are not sufficient.
Here, a more accurate co-culture model was developed that allows the cultivation of
neuronal somata and their axonal processes in separate compartments. A silicon seal
allows for different cultivation conditions in the middle and side compartments while
remaining penetrable for axonal processes. Figure 9 B) shows a schematic draft of a
co-culture chamber with one middle and two side compartments.
Figure 9 C) shows a section of a representative co-culture chamber at day 10 stained
with anti-pan axonal neurofilament marker SMI312 and DAPI. Dissociated dorsal
root ganglion cells were seeded into the middle compartment in neuron specific
medium and adhered over night. Subsequent loading of the side compartments with
the respective growth cues, either NGFβ or skin cells, stated time point d = 0. Total
cultivation period comprised 10 days. The length of a single axonal process varied
between several µm and up to one cm at day 10. Total neurite outgrowth in the side
compartment is quantified as Cumulative Peripheral Neurite Length, CPNL and given
in µm.
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4.1.1 Effect of NGFβ on neuronal fiber growth
The sensitivity of the co-culture system was investigated using nerve growth factor
(NGF). NGF is a potent neurotrophic factor and known to induce neuronal growth and
differentiation. The neurotrophic effects of NGF are mediated by its β subunit [73].
Therefore, recombinant human NGFβ (Sigma) was used to assess NGF induced fiber
growth in the present co-culture system. Increasing concentrations of huNGFβ (0,04
ng/mL, 0,02 ng/mL, 1 ng/mL, 5 ng/mL and 10 ng/mL) were loaded into the side
compartment of the co-culture chambers. Medium served as negative control and
DRGs DRGsSkin Cells NGFβ
SMI 312
DAPI
A B
C
Figure 9: The co-culture system
A)  Anatomical illustration of dorsal root ganglia lateral to the spinal cord
(www.laesieworks.com)
B) The co-culture chamber: DRGs are seeded into the middle compartment; NGFβ or
skin cells are loaded into the side compartments as growth cue. Neurites grow through
the silicon sealed borders.
C) Immunofluorescent picture of a representative co-culture chamber (middle and side
compartment) at day 10. Growth cue: 10 ng/mL huNGFβ. DRGs and peripheral
processes were labeled with mouse monoclonal anti-SMI312, goat anti-mouse Alexa
Fluor 594 and DAPI. Arrows indicate the position of axonal processes in the side
compartment. The picture was taken as a mosaic of 52 images at 100x magnification
with an Axiovert S100 microscope (Zeiss).
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cumulative peripheral neurite growth (CPNL) in the side compartments was
monitored and analyzed at days 4, 5, 6 and 10.
Figure 10 A) shows the increase in CPNL with time. The main increase in growth
occurrs between day 6 and 10 and 10 ng/mL huNGFβ exhibits the greatest growth
promoting effect. In B) the cumulative peripheral fiber growth at day 10 caused by
each concentration of huNGFβ is displayed, a detailed representation of the boxed
section in A). Data were analyzed for non-linear regression, resulting in a sigmoidal
dose-response curve C)  with an R2 of 0,9750. The half maximal effective
concentration (EC50) determined is 4,524 ng/mL.
These results indicate that NGFβ mediates neurite outgrowth in a dose dependent
manner. No outgrowth is caused by medium without stimulus and is therefore run as
negative control in all further experiments. 10 ng/mL huNGFβ exhibits the greatest
outgrowth promoting effect, already in the range of saturation according to the
sigmoidal dose-response curve in C). 10 ng/mL huNGFβ is therefore used as positive
control in further experiments.
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Additionally, an anti-NGFβ antibody (affinity purified, R&D) was applied to
selectively neutralize the growth effects mediated by huNGFβ. The capacity of the
anti-NGFβ antibody to neutralize the biological activity of NGFβ was previously
shown in an 3H-thymidine incorporation assay with TF-1 cells [91]. Here, two types
of experiments were conducted:
First, the capability of the antibody to block NGFβ mediated fiber growth in the co-
culture system was investigated. 10 ng/mL huNGFβ and 2µg/mL antibody were
applied simultaneously in the side compartment and cumulative peripheral neurite
growth was detected.
Figure 11 A) shows the fraction of remaining fiber growth (%) in the presence of the
anti-NGFβ antibody compared to the positive control 10 ng/mL huNGFβ (100 %).
Fiber growth is reduced to ***3,5 ±4,5 %. The ability of the anti-NGFβ antibody to
Figure 10: Neurite outgrowth
induced by recombinant human
NGFβ
A) Total peripheral fiber growth is
monitored at increasing huNGFβ
concen t r a t i ons :  0 ,04_ng/mL,
0,02_ng/mL, 1_ng/mL, 5 ng/mL and
10 ng/mL and compared to negative
control. The cumulative peripheral
neurite length (CPNL) was detected
at days 4, 5, 6 and 10.
B) Cumulative peripheral neurite length at day 10 at increasing concentrations of
huNGFβ. Differences between overall means were analyzed by one-way ANOVA
(***P ≤0,001) followed by Dunnett's multiple comparisons test to compare all columns
vs. control (**P 0,001 – 0,01). C)_Data as in B) analyzed for non-linear regression.
Plotted is a sigmoid dose-response curve (R2 0,9750), EC50 equals 4,524 ng/mL.
(n_=_3, run in duplicates)
***
ANO
VA
A B
C
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neutralize peripheral fiber growth in the co-culture system is considered highly
significant.
Second, it is tested whether the successful sequestration of NGF could be controlled
by detecting unsequestered, free NGF with the Bioplex Cytokine Assay (Bio-Rad). A
complexation assay was conducted. 10 ng/mL huNGFβ were mixed with increasing
concentrations of anti-NGFβ antibody. 10 ng/mL huNGFβ without antibody served as
positive control. Following 15 min incubation at RT the remaining amount of free
NGFβ in solution was detected.
In Figure 11 B) the free amount of huNGFβ in solution (pg/mL) is depicted at
increasing concentrations of anti-NGFβ  antibody: 0,01 µg/mL, 0,05 µg/mL,
0,1_µg/mL, 1_µg/mL and 2 µg/mL. A significant reduction of free NGFβ is achieved
with *0,10 µg/mL, **1 µg/mL and **2 µg/mL antibody.
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Figure 11: Analysis of neutralization capacity of anti-NGFβ antibody
A) Effect of NGF sequestration with anti-NGFβ antibody (2 ng/mL) on NGFβ
(10 ng/mL) induced peripheral fiber growth. The graph shows the percent (%)
of fiber growth in the presence of the antibody compared to the positive control.
Columns were compared by t-test (***P ±0,001). (n = 4, run in duplicates)
B) Sequestration of 10 ng/mL huNGFβ with increasing concentrations of anti-
NGFβ antibody: 0,01 µg/mL, 0,05 µg/mL, 0,10 µg/mL, 1 µg/mL and 2 µg/mL.
Free NGFβ was detected by Bioplex Cytokine assay. Differences between
overall means were compared by one-way ANOVA (**P_0,01 – 0,05).
Individual means were compared to control by Dunnett’s multiple comparisons
test (**P 0,001 – 0,01; *P 0,01 – 0,05). (n = 2, run in duplicates)
A
B
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4.1.2 Characterization of nociceptive DRGs and fibers via IF
staining
In general, dorsal root ganglion cells are classified by the expression of several
neurotransmitters, surface receptors, as well as their binding properties for the plant
lectin IB4 and their neurotrophic dependency on either NGF or glial cell derived
neurotrophic factor GDNF [34]. Dissociated dorsal root ganglion cells of several
species have previously been stained for the expression of these markers [28].
However, reliable quantitative studies of their expression pattern in the peripheral
target tissues, as the skin, remain elusive.
The co-culture system provides the possibility to analyze the expression of sensory
neuronal markers at the peripheral axonal fibers grown in different environments.
Here the nociceptive expression pattern of fibers grown in the presence of 10 ng/mL
huNGβ in the side compartment was investigated via immunofluorescence staining.
At day 10 cells were fixed with 4 % paraformaldehyde (PFA). Somata and peripheral
fibers were labeled for the nociceptive, peptidergic markers calcitonin-gene-related-
peptide (CGRP) and the receptor tyrosine kinase TrkA, the non-peptidergic marker
Isolectin B4 (IB4) and the vanilloid receptor TRPV1. Total peripheral fibers were
labeled with the pan axonal markers SMI312 and PGP9.5, respectively. Cell nuclei
were stained with DAPI.
Figure 12 A) shows representative pictures of DRG somata and peripheral neurites.
CGRP, TrkA, IB4 and TRPV1 are labeled.in green (Alexa 488) and total peripheral
fibers in red (Alexa 594). All four markers are detected to varying extent on somata
and fibers. CGRP, TrkA and IB4 are observed alongside the axonal shafts, whereas
TRPV1 is present at axonal terminals.
B) The graph depicts the quantification of peripheral marker expression. The
fraction_(%) of peripheral fiber length labeled for each marker is compared to
cumulative fiber length (100 %, grey dotted line). TRPV1 is expressed by
approximately 4,6 %, TrkA by 17,8_%, CGRP by 54,7 % and IB4 by 63,8 % of
cumulative peripheral fibers.
C) The table summarizes the relative expression (%), standard deviations (SD and
SEM) and number of experiments per marker (n).
Results
Page 58
Figure 12: Nociceptive expression pattern of NGFβ induced peripheral fibers
Neurite outgrowth was induced by 10 ng/mL huNGFβ. DRGs were fixed at day 10
with 4 % PFA and stained for the nociceptive, peptidergic markers calcitonin-gene-
related-peptide (CGRP) and the receptor tyrosine kinase TrkA, the non-peptidergic
marker Isolectin B4 (IB4) and the vanilloid receptor TRPV1 (Mouse monoclonal anti-
CGRP, rabbit polyclonal anti-TrkA, rabbit polyclonal anti-TRPV1, Isolectin GS-IB4
Alexa Fluor 488 conjugate). Total peripheral fibers were labeled with either mouse
monoclonal anti-SMI312 or rabbit polyclonal anti-PGP9.5. (CPNL, cumulative
peripheral neurite length)
A) Immunofluorescent staining of DRG somata and respective peripheral neurites.
CGRP, TrkA, IB4 and TRPV1 were stained in green with Alexa 488 (Goat anti-mouse
Alexa Fluor 488, goat anti-rabbit Alexa Fluor 488, Isolectin GS-IB4 Alexa Fluor 488
conjugate). Total peripheral fibers were labeled in red with Alexa 594 (Goat anti-
mouse Alexa Fluor 594, goat anti-rabbit Alexa Fluor 594).
B) Expression pattern of CGRP, TrkA, IB4 and TRPV1: Plotted is the fraction (%) of
peripheral fiber length expressing each marker compared to total fiber length (100 %).
Differences between overall means were analyzed by one-way ANOVA (**P 0,001 –
0,01). Individual columns were compared by Bonferroni’s multiple comparisons post-
test (**P 0,001 – 0,01; *P 0,01 – 0,05).
C) Table indicating average total length (%) ± standard deviation for each marker
expressed in the peripheral fibers (n=3; experiments run in duplicates)
Somata Neurites
CGRP
TrkA
IB4
TRPV1
A B
C
63,83 ±
10,10
54,72 ±
20,37
17,79 ±
11,97
4,63 ±
5,74
Mean ±
SD
3333n
IB4CGRPTrkATRPV1
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4.1.3 Stimulation of DRGs and peripheral fibers
It was investigated whether cultured DRGs and their peripheral fibers are functional
and therefore can be stimulated to release the neurotransmitter CGRP, an efferent
function of DRGs. To examine further, whether stimulation of DRGs in the middle
compartment is relayed to axonal terminals in the side compartment, application of
stimuli was confined to the middel chamber. Unspecific stimulation was performed
with high potassium at a concentration of 50_mM (Figure 13). Specific, receptor
dependent stimulation was conducted with 50_nM capsaicin (CPS) that exerts its
function by binding to the receptor TRPV1. The specific inhibition of capsaicin
mediated stimulation was examined with the synthetic TRPV1 antagonist capsazepine
(CPZ), added in a 10-fold excess over CPS at 500 nM (Figure 14).
DRGs were cultivated with 10 ng/mL huNGFβ in the side compartment and subjected
to stimulation experiments at day 10. Each stimulation cycle comprised of a wash
step, 10 min incubation with HEPES buffer to determine basal CGRP release,
followed by 10 min incubation with the stimulus applied to the middle compartment.
After each 10 min incubation period the supernatants of middle and side
compartments were collected. The concentration of CGRP was detected by EIA
(Cayman).
Figure 13 depicts the results for stimulation with high potassium. In A) the CGRP
content of the middle compartment is plotted for two consecutive stimulation cycles.
Basal CGRP release of 60,3 ±43,2 and 72,8 ±17,89 pg/mL after the first and second
HEPES incubation is detected. Following the stimulation with high potassium, CGRP
concentration is increased to *344,2 ±145,0 pg/mL (*P <0,05) in the first cycle and to
**184,4 ±19,7 pg/mL (**P 0,001 – 0,01) in the second cycle. In B) the CGRP content
of the side compartment is plotted for two consecutive stimulation cylces. A basal
release of 5,2 ±7,3 pg/mL and 31,8 ±44,5 pg/mL CGRP in the first and second cycle
is detected. Following the application of high potassium to the middle compartment,
the CGRP content in the side compartment is increased to **105,4 ±4,2 pg/mL
(**P_0,001 – 0,01) for the first cycle and 84,0 ±2,4 pg/mL for the second cycle.
During the second HEPES application, CGRP release does not completely return to
the basal level. Hence, the second basal and induced release of CGRP are not
significantly different. However, the second stimulation is highly significant
compared to the initial basal level during HEPES application in the first cycle.
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Figure_13 C) shows two representative pictures of immunofluorescent labeled
neuronal fibers before (-K+) and after stimulation (+K+). Total peripheral fibers are
labeled with a primary anti-PGP9.5 antibody and stained red with Alexa 594. CGRP
is stained green with a primary anti-CGRP antibody and Alexa 488. Following two
cycles of stimulation the CGRP content of the fibers is clearly reduced.
Hence, the stimulation with high potassium (50 mM) is used as positive control in all
subsequent stimulation experiments.
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Figure 13: Stimulation of CGRP release with potassium
Repetitive stimulation of DRGs with 50 mM potassium at day 10; Neurite outgrowth
was induced by 10 ng/mL huNGFβ. Supernatants of middle and side compartments
were subjected to EIA for quantification of CGRP. Basal CGRP release was detected
in HEPES without stimulus.
A) Middle compartment: CGRP concentration (pg/mL) in the supernatants of two
consecutive stimulation cycles. Differences between overall means were analyzed by
one-way ANOVA (**P 0,001 – 0,01). Individual means were compared by
Bonferroni’s multiple comparisons post-test (*P 0,01 – 0,05) and t-test (***P <0,001;
**P 0,001 – 0,01). (n = 3, total of 14 middle chambers out of 3 piglets)
B) Side compartment: CGRP concentration (pg/mL) in the supernatant of two
consecutive stimulation cycles. Differences between overall means were analyzed by
one-way ANOVA  (*P 0,01 – 0,05). Individual means were compared by t-test (**P
0,001 – 0,01). (n = 3, run in duplicates)
C) Representative pictures of immunofluorescent staining; CGRP in green and
PGP9.5 in red (Mouse monoclonal anti-CGRP, rabbit polyclonal anti-PGP9.5, goat
anti-mouse Alexa 488, goat anti-rabbit Alexa 594) chamber fixed and stained before
stimulation (–K+) and chamber fixed and stained after two cycles of stimulation
(+K+). Pictures were taken at 100x magnification with an Axiovert S100 microscope
(Zeiss).
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Figure 14 shows the CGRP release induced by stimulation with capsaicin (CPS) and
the specific block of CPS stimulation with capsazepine (CPZ) in A), as well as the
persistent unspecific stimulation with high potassium in the presence of CPZ in B).
The first cycle of stimulation is displayed. Detected CGRP concentration is
normalized to cumulative peripheral fiber growth (pg/(mL.µm) to minimize errors
derived from unequal fiber outgrowth.
In A) the stimulation with 50 nM CPS is compared with co-application of CPS and
500 nM CPZ (1:10). CPS elevates the CGRP concentration 2,3 fold compared to its
basal level after HEPES incubation (p 0,0607). On the other hand, co-application of
CPS and CPZ does not increase the CGRP concentration compared to the basal level.
Notably, the CGRP concentration after CPS stimulation compared to the co-
application of CPS:CPZ exhibits a *4 fold (*P <0,05) decrease.
In B) the simultanous application of 50_mM potassium and 500 nM CPZ is indicated.
The CGRP concentration in the side compartment is increased *2,2-fold (*P_<0,05)
compared to the basal level.
In summary, stimulation of DRGs with the TRPV1 agonist CPS is specifically
blocked by its antagonist, whereas unspecific stimulation with potassium is not.
Results
Page 63
Figure 14: Stimulation of DRGs with the TRPV1 agonist capsaicin (CPS) and
antagonist capsazepine (CPZ)
Stimulation at day 10 of neurite outgrowth induced by 10 ng/mL huNGFβ .
Concentration of CGRP (pg/mL) in the supernatant was normalized to cumulative
peripheral neurite growth (CPNL in µm) of the respective side compartment. Basal
CGRP release was detected in HEPES without stimulus.
A) Stimulation with 50 nM CPS and co-application of 50 nM CPS and 500 nM CPZ
(1:10). Plotted is the CGRP content of the supernatant in the side compartment
normalized with total fiber growth (pg/(mL.µm)). Differences between individual
means were compared by t-test (*P 0,01 – 0,05). (CPS/CPZ n = 3; CPS n=4, run in
duplicates)
B) Co-application of 50 mM potassium (K+) and 500 nM CPZ: Plotted is the CGRP
content of the supernatant in the side compartment normalized with total fiber growth
(pg/(mL.µm)). Differences between means were compared by t-test (*P 0,01 – 0,05).
(n = 3, run in duplicates)
HEPES
K+/CPZ
HEPES
CPS / CPZ
HEPES
CPS
A
B
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4.2 NGF expression and secretion by human skin cells
The ability of skin cells to produce and secrete NGFβ has previously been shown by
different groups [100] [101] [102]. In order to address questions about the growth
effects of peripheral axonal fibers mediated by skin cells, the expression and secretion
pattern of NGFβ by keratinocytes and fibroblasts were determined. In addition, the
content of NGFβ in the supernatants of co-cultures with skin cells was detected.
4.2.1 Kinetics of NGFβ expression and secretion
Keratinocytes and fibroblasts were cultivated for 10 days in mono-culture, in an equal
cells per cm2 to volume ratio as in co-culture side compartments. The concentration of
NGFβ in the supernatants of skin cells was detected at day 2, 4, 6, 8 and 10 using the
Bio-Plex Cytokine Assay. In parallel, the total protein concentration of cell lysates
was determined with the BCA Protein Quantification Kit. Detected concentrations of
NGFβ were normalized to respective total protein concentrations.
In a second parallel setup skin cells were lysed and subjected to mRNA isolation at
day 2, 4, 6, 8 and 10. Following reverse transcription the expression levels of NGFβ
were detected by real time PCR using the TaqMan human NGFβ Gene Expression
Assay (Applied Biosystems). Detected Expression levels of huNGFβ were normalized
using the endogenous control 18S rRNA.
Figure 15 summarizes the kinetics of NGFβ expression and secretion by primary skin
cells over 10 days in culture. NGFβ mRNA and protein is detectable in both,
keratinocytes as well as in fibroblasts. In A) ddCt values of NGFβ expression of
keratinocytes and fibroblasts are plotted with cultivation time. Fibroblasts show
significantly higher expression levels compared to keratinocytes at all time points.
This tendency is also reflected in the protein levels shown in B). The normalized
concentration of NGFβ in the supernatants of skin cells per mg total protein (pg/mg)
is plotted with cultivation time. The concentration of NGFβ in the supernatants of
fibroblasts is several folds higher compared to keratinocytes at all time points.
Furthermore, a significant effect on NGFβ levels by days is detected. NGFβ
concentration in the supernatant increases for both cell types with a peak at day 6,
followed by a decrease of levels at day 8 and 10.
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Figure 15: NGFβ expression and secretion by primary skin cells
Keratinocytes and fibroblasts were cultivated for 2, 4, 6, 8 and 10 days. Cells / cm2 to
volume ratio as in the co-culture side compartments. Two parallel setups were
conducted: i) NGFβ in the supernatants was quantified and normalized to total protein
concentration. ii)_mRNA was isolated, transcribed to cDNA and subjected to real time
PCR for the detection of NGFβ expression levels. (n = 2, run in duplicates)
A) Expression levels of NGFβ (ddCt values) in keratinocytes and fibroblasts at day 2,
4, 6, 8 and 10. Expression levels were normalized to the endogenous control 18S
rRNA. Overall expression of NGFβ in keratinocytes and fibroblasts was compared by
two-way ANOVA (**P_0,001 – 0,01). Values of individual time points were
compared by Bonferroni’s post-test (***P ±0,001).
B) Normalized concentrations of NGFβ (pg/mg total protein) in the supernatants of
keratinocytes and fibroblasts at day 2, 4, 6, 8 and 10. Overall NGFβ concentrations in
the supernatants of keratinocytes and fibroblasts were compared by two-way ANOVA
(***P ±0,001). Values of individual time points were compared by Bonferroni’s post-
test (**P 0,001 – 0,01).
Keratinocytes NGF
Fibroblasts NGF
ANOVA **
Keratinocytes NGF
Fibroblasts NGF
ANOVA ***
A
B
Results
Page 66
4.2.2 NGFβ concentration of co-culture supernatants
The content of NGFβ in the supernatants of primary skin cells co-cultivated in co-
culture chambers over 10 days was determined. Cells were seeded in the side
compartments at day 0. Supernatants were subjected to Bio-Plex Cytokine Assay for
NGFβ detection every second day before replacement of the medium.
Figure 16 shows the average concentration of NGFβ in the supernatants of
keratinocytes and fibroblasts in co-culture chambers. Each data set comprises five
values representing the NGFβ concentration at day 2, 4, 6, 8 and 10. Each individual
value is an average of 6 (keratinocytes) and 4 (fibroblasts) experiments, ran in
duplicates. NGFβ concentrations detected are within the same range as previously
defined in 4.2.1. However, no difference of NGFβ levels between keratinocytes and
fibroblasts is observed.
Figure 16: Concentration of NGFβ in supernatants of skin cells in co-culture
chambers
Keratinocytes and fibroblasts were seeded into the side compartment of co-culture
chambers and cultivated for 10 days. NGFβ detection in the supernatants of skin cells
every second day before media replacement.
The graph shows five values representing NGFβ concentrations (pg/mL) at day 2, 4,
6, 8 and 10 of keratinocyte and fibroblast supernatants, respectively. (Keratinocytes
n_= 6; Fibroblasts n = 4, run in duplicates)
day 8
day 4
day 2
day 6
day 10
day 8
day 6
day 10
day 2
day 4
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4.3 Effect of primary skin cells on peripheral fiber growth
Peripheral neurite growth in the side compartment of co-culture chambers is induced
by huNGFβ in a dose dependent manner. Furthermore, keratinocytes and fibroblasts
express and secrete huNGFβ. In the present co-culture system, it was investigated
whether primary skin cells serve as sufficient growth cue to induce peripheral neurite
growth.
In a second step, it was examined whether endogenously produced NGFβ is necessary
for peripheral neurite growth mediated by skin cells. Does NGFβ independent
outgrowth occur in the presence of keratinocytes and fibroblasts, respectively? An
anti-NGFβ antibody (4.1.1) was employed to specifically neutralize growth effects
mediated by secreted NGFβ.
Finally, it was analyzed whether NGFβ independent growth occurs due to a soluble
factor released into the supernatants and therefore can be mimicked by conditioned
media of skin cells.
4.3.1 Peripheral fiber growth mediated by primary skin cells
Keratinocytes and Fibroblasts were seeded into the side compartment of co-culture
chambers and cultivated for 10 days. Respective cultivation media (KGM-2, DMEM,
F12) served as negative controls and 10 ng/mL external huNGFβ was used as high
standard positive control. Peripheral fiber growth was monitored and analyzed at day
10.
Figure 17 A) shows representative pictures of immunofluorescent labeled skin cells
and neurites in co-culture. Total peripheral fibers are labeled in red with anti-pan
axonal neurofilament marker SMI312 or anti-PGP9.5, followed by Alexa 594 coupled
secondary antibodies. Fibroblasts and keratinocytes are labeled in green with anti-
fibroblast surface protein (FSP) and anti-wide spectrum cytokeratin, followed by
Alexa 488. Peripheral neurites induced by fibroblasts and keratinocytes differ in their
phenotype. Fibers entering the keratinocyte layer grow along the cell borders, branch
and wrap around individual keratinocytes (arrows). Fibroblast induced neurites
exhibit minor branching and wrapping. B) shows the quantification of neurite
outgrowth mediated by skin cells compared to control and high standard 10 ng/mL
huNGFβ. Both fibroblasts and keratinocytes are sufficient to induce significant
neurite outgrowth compared to medium control, which equaled zero. Surprisingly,
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keratinocyte mediated peripheral fiber growth exceeds the values achieved by the high
standard 10 ng/mL huNGFβ  with 247.899 ± 234.649 µm compared to
179.978_±10.467 µm. The difference is however not significant. Further, fibroblasts
mediated 44.882 ±19.486 µm CPNL, which is 4 times less outgrowth compared to
10_ng/mL huNGFβ.
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Figure 17: Analysis of neurite outgrowth mediated by skin cells
A )  Immunofluorescent stainings of skin cells in co-culture. Fibroblasts and
keratinocytes labeled in green with Alexa 488 (mouse monoclonal anti-FSP,
polyclonal rabbit anti-wide spectrum cytokeratin; goat anti-mouse Alexa 488, goat
anti-rabbit Alexa 488). Neurites labeled in red with Alexa 594 (mouse monoclonal
anti-SMI312, rabbit polyclonal anti-PGP9.5; goat anti-mouse Alexa 594, goat anti-
rabbit Alexa 594). Pictures were taken as a mosaic at 100x magnification with an
Axiovert S100 microscope (Zeiss).
B) Total peripheral fiber growth (µm) at day 10 mediated by: Control (Ko), fibroblasts,
10mL_huNGFβ and keratinocytes. Individual means were compared to control via one
sample t-test as control equals 0 (*P 0,01 – 0,05). Skin cell mediated fiber growth was
compared to huNGFβ mediated growth by t-test (***P ±0,001). (Ko, fibroblasts n_= 4;
huNGFβ n = 3; Keratinocytes n = 7, run in duplicates)
A
B
Fibroblasts Keratinocytes
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4.3.2 NGFβ independent fiber growth mediated by primary skin
cells
The growth effects mediated by NGFβ secreted by primary skin cells were selectively
blocked by an anti-NGFβ antibody. 0,1 µg/mL antibody (approximately 1000-fold
excess per epitope in reference to the average concentration measured in co-culture
supernatants) was co-applied with keratinocytes and fibroblasts in the side
compartments. Fiber growth was monitored and analyzed at day 10.
Figure 18 shows the cumulative peripheral neurite outgrowth mediated by
keratinocytes in A) and fibroblasts in B). Antibody co-application causes a significant
reduction in fiber outgrowth in the presence of both cell types. However,
keratinocytes mediate a total of 65.912_±39.989 µm NGFβ independent outgrowth,
compared to 3.451 ±2.308 µm mediated by fibroblasts. Co-application of 10 ng/mL
huNGFβ and 2 µg/mL antibody as negative control shows a remaining neurite
outgrowth of ***6.522 ±8.479 µm (4.1.1). Therefore, fibroblast mediated NGFβ
independent fiber growth yields CPNLs below control level.
Figure 18: Analysis of NGFβ dependency of peripheral fiber growth mediated by
skin cells
A) NGFβ dependency of keratinocyte mediated neurite outgrowth: Cumulative
peripheral neurite growth (µm) at day 10 mediated by keratinocytes and keratinocytes
plus anti-NGFβ antibody. Means were compared by t-test (**P 0,001 – 0,01).
(Keratinocytes n = 7; Kerat. anti-NGFβ n = 5, run in duplicates)
B) NGFβ dependency of fibroblast medited neurite outgrowth: Cumulative peripheral
neurite growth (µm) at day 10 mediated by fibroblasts and fibroblasts plus anti-NGFβ
antibody. Means were compared by t-test (**P 0,001 – 0,01). (n = 4; run in duplicates)
A B
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4.3.3 Peripheral fiber growth mediated by conditioned media of
primary skin cells
As NGFβ is secreted into the supernatant by skin cells (4.2), it was investigated
whether conditioned media of keratinocytes and fibroblasts are able to mimic the
growth effect of primary skin cells.
Cell culture supernatants of skin cells cultured for two days at >80 % confluence were
collected and loaded into co-culture side compartments as growth cue. 0,1 µg/mL
anti-NGFβ antibody (approximately 1000-fold excess per epitope in reference to the
concentration detected in conditioned media) was pre-incubated with conditioned
media at RT for 15min and subsequently loaded into the side compartments.
Cumulative peripheral neurite growth was monitored and analyzed at day 10.
Figure 19 shows the cumulative peripheral neurite length mediated by conditioned
medium of keratinocytes in A) and fibroblasts in B). Conditioned media of both,
keratinocytes and fibroblasts mediate fiber outgrowth, with 15.626_±19.287_µm and
459.367 ±415.853 µm, respectively. Co-application of anti-NGF antibody and
conditioned fibroblast medium causes a significant reduction in CPNL of 91,8 %. Co-
application of anti-NGF antibody and conditioned keratinocyte medium caused a non
significant reduction of 39 % CPNL. Though, absolute values differ from the CPNLs
(µm) obtained by skin cells (4.3.2), overall tendency is similar. Different absolute
CPNLs may be due to large standard deviations caused by the inconsistency of
conditioned media.
In summary, conditioned media mimic the effects of keratinocytes and fibroblasts on
fiber growth. Neurite outgrowth mediated by keratinocytes and conditioned
keratinocyte medium likely represents an accumulative effect of NGF and at least one
additional soluble factor. Fibroblast induced fiber growth is NGF mediated.
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4.4 Quantification of NGFβ independent neurite growth
To quantify and compare NGFβ independent peripheral neurite growth detected in
4.3.2, relative values were calculated for each growth condition.
Skin cells and co-applied anti-NGF antibody were loaded in the two side
compartments of the same co-culture chamber. NGFβ independent fiber growth of
one side compartment is expressed as percent (%) of total fiber growth present in the
second side compartment grown without antibody. Co-application of 10 ng/mL
huNGFβ and 2 µg/mL antibody served as negative control.
Figure 20 shows the relative values of NGFβ independent peripheral neurite growth
mediated by keratinocytes and fibroblasts compared to controls. No significant
difference is detected between negative control and fibroblasts, with 3,53 ±4,54 % and
8,94 ±7,48 % CPNL, respectively. However, keratinocytes mediate significant NGFβ
independent outgrowth of **42,93 ±25,61 % CPNL (**P 0,001 – 0,01). Notably, NGFβ
Figure 19: Analysis of NGFβ dependency of peripheral fiber growth mediated by
conditioned media of skin cells
A) NGFβ dependency of conditioned media mediated outgrowth, keratinocytes:
Cumulative peripheral neurite growth (µm) at day 10 mediated by conditioned
keratinocyte medium and co-applied anti-NGFβ antibody. Means were compared by t-
test. (n = 2, run in duplicates)
B)  NGFβ dependency of conditioned media mediated outgrowth, fibroblasts:
Cumulative peripheral neurite growth (µm) at day 10 mediated by conditioned
fibroblast medium and co-applied anti-NGFβ antibody. Means were compared by t-
test (*P 0,01 – 0,05). (n = 5, run in duplicates)
A B
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independent fiber growth induced by keratinocytes is significantly higher compared to
fibroblasts.
In summary, approximately 42,9 % of keratinocyte mediated peripheral fibers grow
independently of NGFβ and are induced by at least one additional factor. Fibroblasts
however induce fiber growth via NGFβ.
4.5 Kinetics of NGFβ independent fiber growth
As previously shown (4.4), keratinocytes mediate significant NGFβ independent
peripheral neurite outgrowth. Here, it was investigated whether neurites mediated by
keratinocytes with and without endogenous NGFβ show different kinetics in growth.
Co-cultures with keratinocytes only and with co-application of anti-NGFβ antibody
were compared. CPNLs in the side compartments were monitored and analyzed at day
4, 6 and 10.
Figure 20: Quantification of NGFβ independent neurite outgrowth
Neurite outgrowth after co-application of primary skin cells and anti-NGFβ antibody
was compared and normalized to skin cell mediated growth. NGFβ independent
neurite growth is expressed as fraction (%) of cumulative peripheral neurite growth
(100 %, grey) of respective control.
Depicted are keratinocytes plus anti-NGF, fibroblasts plus anti-NGF and the negative
control 10 ng/mL huNGFβ plus 2 µg/mL antibody.
Differences between overall means were compared by one-way ANOVA (**P 0,001 –
0,01). Individual means were compared by Bonferroni’s multiple comparisons post-
test (**P 0,001 – 0,01; *P 0,01 – 0,05). (Kerat. anti-NGF n = 6; Fibro. anti-NGF,
huNGF anti-NGF n = 4, run in duplicates)
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Figure 21 shows cumulative peripheral neurite outgrowth at day 4, 6 and 10 mediated
by keratinocytes with and without endogenous NGFβ. The growth curve of both
conditions differs significantly. Notably, there is no difference in CPNLs at day 4,
with 2.110 ±4.532 µm and 1.450 ±1.661 µm, as well as day 6, with 9.646 ±9.761 µm
and 9.404 ±12.216 µm. However, significant difference is detected at day 10, with
double the amount of CPNL grown in the presence of endogenously produced NGFβ.
Neurites enter the keratinocyte layer approximately at day 6.
Figure 21: Kinetics of neurite outgrowth mediated by keratinocytes
A) Cumulative peripheral neurite length (µm) at day 4, 6 and 10 of keratinocytes and
co-applied anti-NGFβ. Growth kinetics of both conditions (*P 0,01 – 0,05) and
increase over days (***P_±0,001) were compared by two-way ANOVA. Cumulative
neurite outgrowth of both conditions were compared at day 10 by Bonferroni’s post-
test (**P 0,01 – 0,05). (n_= 6, run in duplicates)
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5 Discussion
In the present work the role of NGF in the local stimulation of sensory afferent nerve
fiber growth in the skin is investigated using an in-vitro co-culture system of porcine
DRGs and human primary skin cells.
First, the co-culture system is characterized according to its sensitivity to recombinant
human NGFβ and the subtypes of sensory fibers outgrown. The functionality of
cultured sensory neurons is verified via unspecific and specific stimulation and the
detection of released neuropeptides.
Second, the effects of primary human skin cells on the outgrowth of peripheral
sensory fibers is examined. The expression and production of endogenous NGF of
keratinocytes and fibroblasts is detected and correlated with induced fiber growth.
Furthermore, the application of an anti-NGF antibody specifically blocks the trophic
effects mediated by endogenous NGF and allows for the identification of NGF
independent fiber growth mediated by skin cells.
5.1 The co-culture system
In-vivo the cell bodies of sensory afferent neurons are located in the ganglia of the
dorsal root and the cranial nerves. These pseudounipolar cells are clustered together
without dendritic interconnections and surrounded only by glia cells, referred to as
satellite cells [103]. In contrast, sensory nerve fibers in the skin interact and are
associated with multiple different cell types including keratinocytes, fibroblasts,
endothelial cells, Merkel cells, Langerhans cells and mast cells [34]. They form an
extensive three dimensional network in the dermis and epidermis [12] and are
exposed to and express receptors for a multitude of neurotrophic factors,
neuropeptides and cytokines [34]. Free nerve endings (FNEs) accumulate vesicles and
cytoplasmic organelles and release various neuropeptides themselves [105]. Thus,
where the neuronal somata are rather isolated and dependent on satellite cells and
retrograd transport of survival factors, their peripheral terminal endings widely
interact with the cells of the target tissue. Current mixed in-vitro models of peripheral
sensory neurons and skin cells [94] are inadequate as they do not account for the
anatomical spatial separation and the different molecular microenvironments of
somata and nerve fiber endings.
The present co-culture system was developed to more accurately mimic the in-vivo
situation. The neuronal somata and their axonal processes are cultivated in separate
Discussion
Page 76
compartments, sealed by silicon and a sugar polymer mixture. „Peripheral“ axonal
processes are able to grow from the middle into the side compartments and cultivation
conditions are optimized for both, neuronal and human skin cells.
For obvious reason, human DRGs are not available for the co-culture system.
However, murine and rat sensory neurons have been shown to significantly differ in
several sensory neuronal channels, for instance in the expression of Mas-related G-
protein coupled receptors (Mrgprs) [14]. In addition, the expression of molecular
markers as IB4, CGRP and SP and therefore the diversification of nociceptive neurons
varies considerably with species [28]. Furthermore, human skin differs from rat skin
in several aspects of neurogenic inflammation [24]. In recent years, the pig sus scrofa
domestica gained significance as an alternative model organism to rodents in
neuroscience, as there is substantial similarity between human and pig neuronal
anatomy, physiology [106] and pharmacology [107]. In order to establish an in-vitro
model that closely reproduces the in-vivo situation in human skin, porcine DRGs and
human primary skin cells were combined.
5.1.1 Effect of recombinant growth factors on sensory nerve
growth
The co-culture system is sufficiently sensitive to induce peripheral fiber outgrowth in
response to neurotrophic factors. Here, recombinant human NGFβ was applied to the
side compartments in increasing concentrations and mediated peripheral neurite
outgrowth in a dose dependent manner. A minimum of 40 pg/mL were sufficient for
26,464 ±2,217_mm cumulative peripheral fiber growth (CPNL), whereas the high
standard positive control of 10 ng/mL induced a CPNL of 17,997 ±1,046 cm at day
10. In general, axonal processes appeared in the side compartment at day 4 to 5 and
showed largest increase in total length between day 6 and 10. The length of a single
axonal process varied between several µm and up to one cm. Results strongly
indicate, that the present co-culture system is well fit to study attractive as well as
repellent trophic effects on sensory neuronal growth of any given soluble factor.
5.1.2 Quantitative analysis of nociceptive molecular markers in the
peripheral fibers
Dorsal root ganglion cells have been extensively characterized according to the
expression of nociceptive molecular markers as NF200, IB4, SP, CGRP, TrkA and
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TRPV1 [28]. Beside immunofluorescent studies, a combination of fluorescent
labeling and electrophysiology has been applied to relate molecular marker expression
to function [32]. Additionally, sensory neuronal afferents in the skin are detected via
immunohistochemical studies [108]. However, the quantitative detection of molecular
marker expression on neuronal fibers in the skin is challenging. Several markers are
as well expressed on skin cells and cause significant „background“ staining. For
example, keratinocytes express and stain positive for TrkA and TRPV1 [34].
Furthermore, vertical sections of the skin cut through the three dimensional sensory
network, and require sequential cutting and computational reconstruction to suffice a
quantitative approach [14].
In the present co-culture system neuronal somata and their peripheral fibers are
cultivated in spatially separated compartments. In addition to the detection of
nociceptive markers expressed by DRGs, it is possible to quantify the expression of
individual markers in the sensory fibers. Quantitative changes in the expression
pattern as response to different peripheral growth conditions can be detected and
analyzed.
Here, the expression of the nociceptive markers IB4, CGRP, TrkA and TRPV1 was
quantified in periperal afferent fibers grown in response to recombinant huNGFβ. IB4
and CGRP expression was prevailing with 63,8 % and 54,7 %, respectively. These
values strongly indicate a significant overlap between the two markers in peripheral
sensory afferents, as it has been shown for DRGs [28]. However, double staining of
both markers for the verification and quantification of the overlap is pending. The
NGF high affinity receptor TrkA was detected along 17,8 % and TRPV1 at 4,6 % of
CPNL. The small relative number of TRPV1 expression may at least in part be
explained by the nature of its expression pattern. The TRPV1 signal was confined to
the fiber endings, whereas IB4, CGRP and TrkA were observed alongside the axonal
shafts. Thus, besides the relative values of CPNL positive for individual molecular
markers, a qualitative conclusion of the expression pattern can be drawn.
5.1.3 Specific and unspecific stimulation of efferent functions of
sensory neurons
Besides their various receptive properties, sensory neuronal afferents are able to
release neurotransmitters, neuropeptides and neurohormones [34]. In the skin, this
local efferent function of sensory afferent neurons is involved in a complex auto and
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para-neuroendocrine system between nerve fibers, skin cells, immune cells and the
microvascular system [24] [33] [34].
Two distinct mechanisms for the efferent release of neuropeptides have been
described. The classical model of the axon reflex was first proposed by Lewis 1927
[109] and originally associated with vasodilatation and plasma extravasation during
the weal and flare response to focal skin irritation. To date, the concept has been
expanded to neurogenic inflammation in general, including also non-vascular effects
mediated by neuropeptide release, sensitization of sensory afferents and immune cell
activation [110] [36]. Peripheral sensory afferent depolarization results in a pulse that
travels centrally, but induces antidromically proceeding signals at branching points of
the same neuron. Antidromic signals travel back to the periphery and result in the
release of neuromediators from the fiber endings. However, this picture is incomplete
as the induction of peripheral flare response by histamine injection [111] and
cutaneous inflammation following capsaicin injection [104] is abolished by removal
of DRGs and distal dorsal root rhizotomy, respectively. Intact DRGs and the
involvement of neuronal somata seem crucial to efferent functions of sensory
afferents mediated by axon reflex.
As direct stimulation of the dorsal root was shown to induce antidromic vasodilatation
[109] [112], a similar approach was chosen to test the functionality of sensory neurons
grown in the present co-culture system. The cell somata in the middle compartment
were subjected to stimulus application, whereas the efferent release of neuropeptides
of the peripheral fibers in the side compartment was detected.
The neuropeptide CGRP is considered the most abundant neuropeptide in Aδ and C
fibers in the human skin [50]. It constitutes the predominant neuropeptide in DRGs
expressed by approximately 40 % of the somata (rattus norvegicus) [34] and is
expressed by 63,8 % of peripheral CPNL in the present co-culture system (5.1.2).
Therefore, the efferent release of CGRP into the supernatant was chosen as the
readout parameter.
Neuropeptides are released from C and Aδ fibers in response to a wide range of
internal and external stimuli. Intradermal injection of capsaicin mediates neurogenic
inflammation via the axon reflex mechanism and involves the peripheral release of SP
and CGRP [104]. In the same setup, neurogenic inflammation is completely abolished
by the application of the TRPV1 antagonist capsazepine in a dose dependent manner.
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In the present co-culture system the capsaicin receptor TRPV1 is expressed by
neuronal somata. Therefore, capsaicin and capsazepine were chosen for the specific,
receptor mediated stimulation and block of CGRP release, respectively. Unspecific
stimulation with high potassium (50 mM) was used as positive control [99].
Both, unspecific high potassium and specific capsaicin mediated stimulation of
neuronal somata resulted in efferent CGRP release in the side compartment. High
potassium application yielded an approximately 20-fold increase in CGRP levels
compared to basal release. Repetitive stimulation was accomplished, however basal
CGRP levels between two cycles did not completely return to the initial basal level.
Specific stimulation with capsaicin resulted in a 2,3-fold increase in the peripheral
CGRP levels, whereas the co-application of capsaicin and capsazepine did not
stimulate CGRP release above the basal level. Thus, capsazepine specifically blocked
capsaicin mediated CGRP release, whereas the co-application of high potassium and
capsazepine yielded a 2,2-fold increase in CGRP levels.
In addition to the axon reflex concept, the direct release of neuromediators from the
stimulated sensory afferent terminals of capsaicin sensitive neurons has been shown
[113]. This local coupling of the afferent and efferent function of sensory neurons
plays a key role in the intercellular crosstalk and skin homeostasis. Although these
experiments have not been performed in the present thesis, direct stimulation of the
peripheral fibers is also feasible.
Since DRGs are spatially separated from the peripheral fibers, it seems further
possible to investigate changes in the peripheral efferent functions during application
of central acting substances. An equivalent mechanism in-vivo is the presynaptic
inhibition of the central projections of primary afferent neurons in the spinal cord
[110].
CGRP positive afferent fibers in the skin are often associated with keratinocytes,
melanocytes [54], Merkel cells, Langerhans cells [55] or mast cells [56]. These cell
types also play an important role in inflammatory conditions [34]. Using the co-
culture system, the investigation of efferent functions of sensory afferents in co-
culture with virtually any other cutaneous cell type is possible. Notably, the efferent
release of neuromediators from peripheral fibers may be directly quantified in the
supernatant.
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5.2 Neurotrophic effects of human skin cells on sensory
neurons
In several cutaneous diseases significant changes in the epidermal neuronal fiber
density and morphology has been detected. In atopic dermatitis (AD) and Psoriasis
peptidergic SP+ CGRP+ fiber density is increased [89] [88], wherease diabetic
neuropathy shows a reduction in unmyelinated epidermal C fibers [114]. Consistently,
the level of NGF is elevated in AD [108] and psoriasis [115], and depleted in the skin
of early diabetic neuropathy [70] [116]. Further, NGF regulates the production of
neuropeptides in sensory afferents. Neuropeptides have an influence on the production
and release of cytokines, as TNFα, IL-1 and INFγ that in turn stimulate the cutaneous
expression of NGF, NT-3 and NT-4 [117]. Thus, a strong neurogenic component is
suggested in the development and sustainment of cutaneous diseases.
In this thesis, the local influence of primary human dermal and epidermal skin cells on
sensory afferent nerve growth is investigated using the co-culture system. Both,
keratinocytes and fibroblasts were sufficient to induce sensory fiber outgrowth.
Surprisingly, keratinocyte mediated outgrowth exceeded the CPNL of the high
standard 10 ng/mL recombinant huNGFβ, though not significantly. Fibroblasts
induced substantial peripheral fiber growth, however only 25 % of the CPNL
mediated by keratinocytes.
The concentration of endogenously produced NGFβ of primary skin cells in the co-
culture chamber was detected in parallel. The supernatants of keratinocytes and
fibroblasts contained similar concentrations of average 23,8 pg/mL and 19,4 pg/mL
NGFβ, respectively. However, the NGFβ concentrations did not correlate with
induced total fiber outgrowth. Keratinocytes induced an average CPNL of 247,9_mm,
whereas fibroblasts only mediated 44,9 mm. Furthermore, the 500-times higher
concentration of 10_ng/mL recombinant huNGFβ induced an average CPNL of
180_mm, which is 4-times the CPNL obtained by fibroblasts, but only 0,7-times that
of keratinocytes.
Although differences in the trophic capacity between endogenously and
recombinantly produced huNGFβ are possible, the vast difference in CPNL of
keratinocytes and fibroblasts occurred in the presence of equal concentrations of
endogenous NGFβ. The involvement of at least one other keratinocyte derived
component seemed likely to account for this difference.
Discussion
Page 81
To identify potential NGF independent fiber growth, a specific anti-NGFβ antibody
was co-applied with primary skin cells to inhibit the biological effects of endogenous
NGFβ. The CPNL of fibroblasts decreased to the negative control level in the
presence of the antibody, whereas keratinocytes mediated 42,9 % NGF independent
CPNL. Hence, keratinocytes and fibroblasts showed significant difference in NGFβ
dependency to promote neurite growth. Whereas fibroblast mediated outgrowth is
considered to be dependent on NGFβ, only 57,1 % of keratinocyte mediated CPNL is.
The results were reproducible with conditioned media. Thus, NGF independent
keratinocyte mediated growth is likely caused by at least one additional soluble factor.
5.2.1 Difference in morphology of peripheral fibers mediated by
keratinocytes and fibroblasts
Differences in the trophic effects of keratinocytes and fibroblasts on fiber outgrowth
were also detectable via immunofluorescent analysis. Neurites stimulated by
keratinocytes exhibited extensive branching and fibers wrapped around individual
cells. No difference in morphology was detected between keratinocyte induced
neurites and NGF independent keratinocyte induced neurites (data not shown). On the
other hand, fibroblasts mediated peripheral fibers of an unbranched, straight
phenotype with minor wrapping. Thus, besides the distinct dependency on NGF for
the induction of fiber growth, both cell types exert crucial influence on the local
morphology of sensory afferents.
5.2.2 Kinetics of NGF independent growth mediated by
keratinocytes
In addition, the kinetics of fiber outgrowth induced by keratinocytes with and without
anti-NGFβ antibody was significantly different. No difference in CPNL was detected
at day 4 and 6. However, at day 10 NGF independent CPNL scores only 42,9 %
compared to fiber growth in the presence of endogenous NGFβ. Neurites entered the
keratinocyte layer of the co-culture system approximately at day 6.
It is concluded that NGFβ is not necessary for neurites to enter the side compartments,
extend and reach the keratinocyte layer. In general, increase in CPNL is most
prominent between day 6 and 10, as shown in growth curves with external huNGFβ.
It is hypothesized that NGFβ is mainly necessary for the increase and growth in
length, in consistence with the immunofluorescent analysis of neurite morphology
(5.2.1).
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5.3 Potential additional keratinocyte derived factors in
sensory fiber outgrowth – GDNF
Glial cell-line derived neurotrophic factor is a distant member of the TGFβ
superfamily based on structural and conformational similarities. The active
homodimer binds the GDNF family receptor α (GFRα1), induces recruitment and
autophosphorylation of the receptor tyrosine kinase Ret and intracellular signaling via
Src kinase [118]. Approximately half of the TrkA+, NGF dependent DRGs switch
their expression pattern and dependency towards GDNF in early postnatal life [31].
Subsequently, GDNF mediates the survival of IB4 positive, non-peptidergic, small
diameter sensory afferents of both the somatosensory and the autonomic nervous
system [119].
Immunofluorescent analysis and RT-PCR of human skin showed strong expression of
GDNF, GFRα1/2 and Ret in all epidermal layers, whereas GDNF gradually decreases
with ascending keratinocyte layers [65]. In addition, preliminary data obtained in this
thesis via real time PCR of primary human skin cells, revealed equal expression levels
of GDNF and NGF in keratinocytes. In human fibroblasts GDNF expression was
significantly lower than NGF expression, though still higher than the GDNF level
measured in keratinocytes (preliminary data, not shown).
Additionally, GDNF is implicated in cutaneous diseases as AD, inflammation and
hyperalgesia. GDNF production was found enhanced in the epidermis of two distinct
mouse models of atopic dermatitis [120]. Injection and overexpression of GDNF in
the skin of rat [121] and mouse [122] significantly reduced the thresholds of
mechanical stimulation and led to sensitization of nociceptors and mechanical
hyperalgesia. Furthermore, inflammatory conditions induced by radiant heat led to
gradually enhanced secretion of GDNF in DRGs and induced a specific increase in
TRPV1 expression on IB4 positive neurons [82].
Taken together, GDNF would present a quite reasonable candidate for the detected
induction of NGF independent peripheral fiber growth mediated by keratinocytes.
Further experiments are needed to determine the potential of GDNF to stimulate fiber
outgrowth and the induced sensory fiber types. Subsequent combinations of anti-NGF
and anti-GDNF antibodies co-applied with keratinocytes allow the quantification of
GDNF dependent peripheral sensory afferents.
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6 Abstract
In this work, the local influence of dermal and epidermal skin cells on sensory
afferent nerve growth was investigated using a novel in-vitro co-culture system of
porcine dorsal root ganglion cells (DRGs) and human primary skin cells.
The co-culture system allows for the cultivation of cell somata and peripheral
neuronal processes in spatially separated compartments that are liquid-impermeable.
In accordance with the in-vivo situation, only the axonal processes of sensory neurons
were co-cultivated with dermal and epidermal skin cells in the „peripheral“
compartment. This approach allows to study the neuronal cutaneous network in-vitro.
In a first attempt, the co-culture system was established and characterized. The
sensitivity of the system in response to the neurotrophic factor human NGFβ was
examined. Recombinant huNGFβ induced a dose-dependent outgrowth of peripheral
sensory fibers in a range between several pg/mL to 10 ng/mL. The major increase in
cumulative peripheral neurite length (CPNL) was detected between day 6 and 10 of
cells in culture.
Subsequently, subtypes of peripheral sensory fibers grown in response to huNGFβ
were characterized and quantified via immunofluorescent staining for the nociceptive,
peptidergic markers calcitonin-gene-related-peptide (CGRP) and receptor tyrosine
kinase TrkA, the non-peptidergic marker Isolectin B4 (IB4) and the vanilloid receptor
TRPV1. IB4 and CGRP expressions were prevailing with 63,8 % and 54,7_%,
followed by TrkA with 17,8 % and TRPV1 with 4,6 % of CPNL, thus confirming the
nociceptive sensory phenotype of the grown fibers.
The functionality of the cultured sensory neurons was verified via unspecific
stimulation with high potassium (50mM) and specific stimulation with the TRPV1
agonist capsaicin (CPS) and inhibition with the antagonist capsazepine (CPZ),
respectively. Unspecific and specific stimulation of the somata in the middle
compartment resulted in an efferent release of the neuropeptide CGRP in the
peripheral side compartment. The CPS mediated stimulation of TRPV1 was
successfully inhibited by the receptor specific antagonist CPZ, further emphasizing
the functionality of the cultured neurons.
Finally, the neurotrophic effects of keratinocytes and fibroblasts on peripheral sensory
fiber outgrowth was investigated. Both cell types were sufficient to induce substantial
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sensory fiber outgrowth. Surprisingly, keratinocyte mediated CPNL exceeded the
outgrowth mediated by recombinant huNGFβ.
Additionally, co-application of an anti-NGFβ antibody decreased fibroblast mediated
growth to negative control level, whereas keratinocytes mediated growth was only
reduced to 42,9 %. These results indicate that fibroblasts induce fiber growth mainly
via NGF, whereas keratinocytes produce at least one additional soluble factor that
accounts for the NGF independent fiber growth.
Comparison of keratinocyte mediated outgrowth with and without anti-NGFβ
antibody revealed no difference in CPNL values at day 4 and 6. As neuronal fibers
usually reached the keratinocyte layer at day 6, NGF seems not necessary for neurites
to enter the side compartment, extend and reach the keratinocytes. NGF may rather
play a role for the increase in length between day 6 and 10, consistent with the
reduction of 57,1 % of CPNL without NGF.
Further consistent with this hypothesis was the analysis of fiber morphology. Neurites
stimulated by keratinocytes exhibited extensive branching and frequently wrapped
around individual cells. On the contrary, fibroblasts mediated fibers of more
unbranched and straight phenotype.
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7 Zusammenfassung
Im Rahmen dieser Arbeit wurde der Einfluss von dermalen und epidermalen
Hautzellen auf das Wachstum von peripheren sensorischen Nerven in einem neuen in-
vitro Kokultur-Modell untersucht.
In diesem Modell werden neuronale Zellkörper und ihre peripheren Fortsätze örtlich
getrennt in separaten, flüssigkeitsdichten Kammern kultiviert. Entsprechend den
Gegebenheiten in-vivo, wurden dermale und epidermale Hautzellen ausschließlich mit
den neuronalen Fortsätzen in der „peripheren“ Seitenkammer kultiviert. Dieses
spezielle Setup ermöglicht die Untersuchung des peripheren neuronalen Netzwerks in
der Haut in-vitro.
Im ersten Schritt der Arbeit wurde das Kokultur-Modell etabliert und charakterisiert.
Die Sensitivität des Systems auf neurotrophe Faktoren wurde mittels humanem NGFβ
analysiert. Rekombinantes huNGFβ  induzierte dosis-abhängiges peripheres
Neuritenwachstum in einem Bereich von wenigen pg/mL bis hin zu 10_ng/mL. Die
größte Zunahme an der gesamten peripheren Neuriten Länge (cumulative peripheral
neurite length, CPNL) wurde zwischen dem sechsten und zehnten Tag der
Kultivierung beobachtet.
Die von huNGFβ induzierten peripheren Fortsätze wurden im Anschluss mittels
Immunfluoreszenzfärbung charakterisiert und quantifiziert. Detektiert wurden die
Marker für sensorische, nozizeptive, peptiderge Neurone Calcitonin-gene-related-
peptide (CGRP) und Receptor tyrosine kinase TrkA, der sensorische, nozizeptive,
nicht-peptiderge Marker Isolectin B4 (IB4) und der Vanilloid Rezeptor TRPV1. Die
Espression von IB4 und CGRP war mit 63,8 % und 54,7 % am stärksten detektiertbar,
gefolgt von TrkA mit 17,8 % und TRPV1 mit 4,6 %. Der positive Nachweis dieser
Marker bestätigt die Präsenz von sensorischen, nozizeptiven Fasern im vorliegenden
Modell. Dabei kann zum ersten Mal eine quantitative Aussage über das
Expressionsmuster dieser Marker in den peripheren Fasern, abhängig von den
Wachstumsbedingungen gemacht werden.
Die Funktionalität der kultivierten Neuronen wurde mittels unspezifischer Stimulation
mit 50 mM Kalium und spezifischer Stimulation mit dem TRPV1 Agonisten
Capsaicin (CPS), sowie Inhibition mit dem Antagonisten Capsazepin (CPZ) bestätigt.
Sowohl unspezifische als auch spezifische Stimulation der neuronalen Somata in der
Mittelkammer bewirkten die efferente Ausschüttung des Neuropeptids CGRP in der
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peripheren Seitenkammer. Die Stimulation von TRPV1 mittels CPS wurde erfolgreich
durch den Rezeptor-spezifischen Antagonisten CPZ inhibiert und bestätigt erneut die
Funktionalität der kultivierten Neurone.
Schließlich wurde die neurotrophe Wirkung von Fibroblasten und Keratinozyten auf
das Wachstum der peripheren neuronalen Fortsätze untersucht. Beide Zelltypen
induzierten erhebliches Neuritenwachstum, wobei Keratinozyten sogar höhere CPNL
Werte erzielte als recombinantes huNGFβ. Bei gleichzeitiger Anwendung eines anti-
NGFβ  Antikörpers wurde das von Fibroblasten induzierte Wachstum auf
Kontrollniveau reduziert, wohingegen Keratinozyten vermitteltes Wachstum nur auf
42,9 % verringert wurde. Diese Ergebnisse deuten darauf hin, dass Fibroblasten
induziertes Neuritenwachstum größtenteils durch NGF vermittelt wird. Keratinozyten
scheinen hingegen zumindest einen zustätzlichen, sekretierten Faktor zu produzieren,
der für das verbleibende, NGF unabhängige Wachstum verantwortlich ist.
Im Vergleich zwischen Keratinozyten vermitteltem Neuritenwachstum mit und ohne
anti-NGFβ Antikörper, zeigte sich keinerlei Unterschied in den CPNL Werten am Tag
4 und 6. Da Neurite üblicherweise die Keratinozytenschicht am Tag 6 erreichen,
scheint NGF nicht notwendig für das Auswachsen und Erreichen der Keratinozyten zu
sein. NGF spielt möglicherweise eine größere Rolle im Längenwachstum zwischen
Tag 6 und 10, wo sich ein Unterschied von minus 57,1 % ohne NGF manifestiert.
Mit dieser Annahme gehen auch Beobachtungen der Morphology der Neurite
konform. Keratinozyten vermittelten Fortsätze mit einem hohen Grad an
Verzweigungen, die häufig einzelne Zellen umwickelten. Hingegen wiesen
Fibroblasten induzierte Fasern einen geradlinigen, gering verzweigten Phänotyp auf.
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9 Abbreviations
µg Microgram
µL Microliter
µm Micrometer
AD Atopic Dermatitis
BDNF Brain-derived neurotrophic factor
CGRP Calcitonin gene-related peptide
CNS Central nervous system
CPNL Cumulative peripheral neurite length
CPS Capsaicin
CPZ Capsazepine
CRLR Calcitonin-receptor-like-receptor
CT Calcitonin
DAPI 4',6-diamidino-2-phenylindole, dihydrochloride
DMEM Dulbecco's Modified Eagle Medium
DRG Dorsal root ganglia
EC50 Half effective concentration
GDNF Glial cell-derived neurotrophic factor
GFRa1-4 GDNF family receptor alpha 1-4
HDMECsHuman dermal microvascular endothelial cells
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
huNGFb Recombinant human NGF
IB4 Isolectin B4
IL Interleukin
m/s meter per seconds
max. Maximum
min Minutes
mL Milliliter
n Number of independent data sets
NF200 Heavy neurofilament 200 kDa
ng Nanogram
NGFb Beta subunit of Nerve growth factor
NK Neurokinin
NT-3 Neurotrophin-3
NT-4 Neurotrophin-4
PACAP Pituitary adenylate cyclase activating protein
PBS Phosphate buffered saline
PNS Peripheral nervous system
POMC Proopiomelanocortin
RAMP Receptor-activity-modifying-protein
RT Room temperature
SP Substance P
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SST Somatostatin
TG Trigeminal ganglia
TNFa Tumor necrosis factor alpha
TrkA Receptor tyrosine kinase A
TRPV1 Transient receptor potential vanilloid 1
UV Ultraviolet light
VIP Vascular intestinal peptide
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